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Ethanol is well studied with regard to its teratogenic effects in different animal models 
including humans. Exposure of a fetus to alcohol during pregnancy can lead to fetal alcohol 
syndrome (FAS), or ethanol mediated toxicity in animal models. 
 
During early embryogenesis, development of the most important organs including the central 
nervous system (CNS) occurs. Disturbance of any function that contributes to the normal 
development can lead to defects and dysfunctions of the brain and other important organs. 
Zebrafish (Danio rerio) is a small fresh water fish increasingly being used as a model system 
for human disease, drug development and safety pharmacology. 
It is also a perfect model for studying the effects of ethanol on molecular level due to the 
similarities between zebrafish and humans with regards to genetic cascades and signaling 
pathways during early embryogenesis. 
 
Genes that are members of Pax and Atoh families of transcription factors are expressed in 
specific parts of the brain. Visualization of gene expression by using in situ RNA 
hybridisation can provide useful information about the brain development of embryos 
exposed to drugs compared to their normal counterparts. An important part of the project was 
therefore to isolate RNA and make cDNA, so that the Atoh1a and Atoh1c genes could be 
cloned and used as probes for in situ hybridisation. Probes for in situ hybridisation with 
Pax6.1 and Pax2.1 were already available. 
 
Zebrafish embryos were incubated in different concentrations of ethanol 0.01 %, 0.1 %, 1 % 
and 2 % for three days. After every 24 hours within the three days the embryos were observed 
in a dissecting microscope and development changes and mortalities were recorded. Embryos 
incubated in 2 % ethanol were overall deformed, while embryos incubated in 1% ethanol 
developed malformations including pericardial edema, yolk sac edema, axial malformations, 
axial blistering and truncated body axis. Some of the embryos had late development and were 
inactive. In situ hybridisations were done to look for changes in the brain and eye 
morphology. In addition, changes in Pax6.1 gene expressions were paid extra attention 
because it is previously reported that ethanol decreases the level of Pax6 expression. 










ZFE- Zebrafish embryo 
ICH-International Conference on Harmonization 
ADME- Absorption, distribution, metabolism and Excretion 
MHB-Midbrain-hindbrain boundary 
NCE- New chemical entity 
HPF- Hours Post fertilization 
MO- Morpholino oligonucleotide 
FAS- Fetal alcohol Syndrome 
FASD- Fetal alcohol related disorder 
ARBD- Alcohol related birth defects 
ARND- Alcohol related neurodevelopment disorder 
HTS- High throught-output screening 
CNS- Central nervous system 
HSPGs- Heparan Sulfate proteoglycan  
DPF- days after postfertilzation 
SHH- Sonic hedgehog 
FGF- Fibroblast growth factor 
DNA- Deoxyribonucleic acid 
RNA- Ribonucleic acid 
RT- Room temperature 
O/N- Over night 
RPM- Round per minute 
SAP- Shrimp alkaline phosphatase 
RT-PCR- Reverse Transcriptase Polymerase chain reaction 
PCR- Polymerase chain reaction 
ETOH- ethanol 
ISH- In situ hybridisation 
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1.1. Zebrafish and safety pharmacology 
Safety Pharmacology studies are defined as those studies that investigate the potential 
undesirable pharmacodynamics effects of a substance on physiological functions in relation to 
exposure in the therapeutic range or above (1). 
 
This method is used to find out about unknown or possible adverse effects of drugs before 
they are out of the market. It is also a way of finding out interaction of a molecular target 
different from the intended one hence causing toxic effects. 
 
International conference on Harmonization (ICH) approved the S7A guidelines in 2000 for 
safety pharmacology. This requires the pharmaceutical companies to take safety assessments 
of drugs under (Good laboratory practice) GLP in order to secure on the possible toxic effects 
of drugs before they are tested on humans (2). 
 
ICH guides provides the battery core that each new chemical entity (NCE) need to be 
evaluated on, including the Cardiovascular, CNS and the respiratory system (3). 
 
The number of NCE submitted to FDA have been declined about half since 1997.FDA points 
in a recent report that technological deficits in toxicology as the primary cause of the pipeline 
problem. New animal models are needed to test the safety novel drug candidates and the FDA 
report that an estimated 10 % improvement in predicting failures before clinical trials would 
save US $100 million per drug in development costs. In addition to outdated technologies 
toxicology often suffers by being divorced from the drug discovery process. Efforts to 
discover leads happens simultaneously as the toxicology assessment, some efforts are made to 
discover the toxicology in early discovery process but much more progress is needed to 
develop better animal models for toxicological assessment and to discover toxicology earlier 
in the drug discovery process (4). 
 
Models like mice, rabbits, rats and dogs have been used for drug testing in decades, but 
handling of the animals is time consuming and expensive. 
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Mammalian models of absorption, metabolism, distribution, excretion (ADME) 
pharmacokinetics are expensive, laborious and require large amount of compound. Besides 
the consideration that it requires legal welfare legislation, there is an increase pressure to limit 
animal use in situations, which are absolutely necessary, nevertheless that it requires 
dissection of a whole animal, which makes the zebrafish a promising model for studying 
toxicology. Most of the drug companies prefer zebrafish as their first model in clinical trials 
because of its size and less cost. It is also said that the embryos are unlikely to consider pain 
and sufferings (0-5dpf) (5). 
 
During the past five years new methods for in vivo drug assay have been discovered which 
make zebrafish the perfect model for studying disease-modeling, lead-target discovery for 
compounds and toxicology. Once a lead target has been identified in vitro HTS on target 
binding can be used to identify the novel structures that modify the binding of the target 
protein. Practically zebrafish is a perfect model because in vitro assays require small 
quantities of compounds, takes less space and it’s a simpler phenotype in comparison to 
mammalian essay (4). 
 
 
1.2. The zebrafish and its benefits 
Zebrafish (Danio rerio) originally predominate from South East Asia and are broadly 
distributed in parts of Pakistan, India, Nepal, Bangladesh and Mynmar and was introduced as 
a genetic model organism by George Streisinger in the late 1960s (6, 7). 
Zebrafish have emerged in the past twenty years as a useful vertebrate for studying genetics 
and development of human diseases, and it has several characteristics that make them 
preferably beneficial instead of other model organisms including: 
 
Small size and less economical costs 
The small size of the embryos (1-2 mm long) makes it easier for researching on a 96-well 
dishes and it requires less costs on reproduction and to maintain them. Their small size makes 
them more useful for microscopic assays and other types of screening. 
One pair of zebrafish can lay 200-300 eggs during spawning and the same pair of fish can be 




Rapid generation time 
Zebrafish embryos develop quickly from the time the eggs are spawned Since fertilization is 
outside the mothers (intra-utero) it grastulation starts at 6hpf and embryogenesis is completed 
around 96hpf (9), followed immediately by the segmentation stage where the somites are 
formed. By 24 hpf, somitogenesis is completed and many organ rudiments have been laid 
down. Embryos are motile and motility has become touch evoked by 28–30 hpf resulting in 
the first behavior, the startle response. By 5 days post-fertilization (dpf), embryos start 
feeding suggesting that most organs have reached a functional state by this time (10). At  
48 hpf the zebra fish has generated parts of the organs and organogenesis is completed (11). 
 
Optical transparency  
Transparency of embryos at early stage of embryogenesis makes them easy to be visualized 
intact. The optical clarity of the embryo becomes even more useful when combined with 
fluorescent markers that highlight the locations or activities of specific populations of cells.  
Optical transparency makes it easier to determine phenotypic changes during mutagenesis 
screening and finding out toxicity during toxicity assay. Methods like RNA In situ 
hybridization and immunochemistry can be used to screen for chemical-induced abnormalities 
in the expression of specific genes (8). 
 
Genetic similarities 
Zebrafish share genetic similarities to humans and tractability in forward and reverse genetic 
screens. Mutations have been screened and over 400 genes have been cloned, Screen for 
diseases like Polycystic kidney disease, cholesterol processing, tissue generation, heart 
disease, anemia’s, caner and nervous system (4). 
Another thing is high nucleotide sequence similarity in comparison to humans, including 
morpholino oligonucleotides screen (6, 12). 
There is 80% of genes that are analyzed which link zebrafish to human genome (13) 
Morpholino oligonucleotides (MOs) are antisense nucleic acid analogs that have ribosides 
converted to morpho- lines (C 4H9NO) and a phosphorodiamidate intersubunit link- age 
instead of phosphodiester linkage. They work by binding to, and blocking translation of 
specific mRNA. MOs have been shown to successfully knockdown gene expression in zebra 
fish embryos (8). 
 By systematically knocking down many genes, it should be possible to identify gene 
knockdowns that prevent or slow the development of the disease phenotype 
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Genetic screening is an efficient way of individualizing the roles of different genes in disease 
process. They possess a beneficial route in identification and validation of novel drug targets 
(4). 
 
High Through-output screening 
The modern concept of High throughout put screening (HTS) involves automatic robotic 
system that process basic screening procedure, which would involve obtaining zebrafish 
embryos of the same development stage, loading them into multi-well plates 96, 384 or more, 
dosing the plates and imaging or otherwise to obtain the data on changed elicited but the 
drugs. HTS can be used to assess many ADME issues upfront. Phenotype screening have 
been described as chemical genetic screen, therapeutic screen, transgene assisted screen and 
pathway reporter screen (14). 
There are several levels of images that can apply on HTS toxicity analysis. 
White field microscopy which detects growth defects on the embryo development, Including 
egg coagulation and other deformities. Structural changes implicating specific tissues can be 
performed using transgenic zebra fish lines harboring fluorescent derivatives of specific 
proteins. 
Transgenic zebrafish lines can be used to identify tissues for specific proteins by using 
fluorescence assays that monitor the expressions. If the output reflects changes in the 
fluorescence intensity, giving results that are comparable to real time PCR assays, with the 
advantage that fluorescence signal can be followed in vivo during the normal development of 
the individual. This method allows the monitor of primary transcriptional effects, which is 
useful to determine the mode of action of a given substance or to predict its overall toxicity 
even at lower concentrations. 
The use of cameras combined with appropriate algorithms allows the recording of reaction 
base phenotypes particularly important when dealing with neuroactive compounds. Similar 










1.3. Zebrafish and toxicology 
The zebrafish have been used for researches and it has been very beneficial in finding 
toxicological effects of different compounds. It has been used to find preclinical effects, 
safety and efficacy of drugs. 
 
Zebrafish can be used as a model to test different diseases in human such as cardiovascular 
diseases, renal impairment, cancer, hearing loss, homeostasis and anemia, as well as 
neurological disorders (15). 
 
 It has a very simple nervous system that can be used to study neurotoxiocology, and its 
transparent at early stages makes it even easier to study the neural structures and 
malformations. 
 
Toxicology in zebrafish requires small quantities of compounds (g) in comparisons on 
testing in other organisms like mammals (4) 
 
Similarities between zebrafish and humans: 
 
Different studies have found out that mechanism of how drugs works are being conserved 
between zebra fish and mammals. Small toxicity responses have been discovered on areas like 
the endocrine system, reproductive toxicity, behavioral defects, teratogenesis, carcinogenesis, 
cardio toxicity, ototoxicity, liver toxicity and so on. 50-70 % of the way chemicals affects the 
cell cycle in mammals is similar to zebra fish cell cycle. This may reflect to high degree of 
amino acid frequency between zebra fish and human drug targets. Other studies show even 
great degrees of similarity up to 95 %, this might be cause of the way protein binds to 
different drug targets (4). 
 
The blood brain barrier in the fish is said to be the same as in humans. Blood brain barrier is 
regulated by endoepithelial cells in the blood vessels. These are sealed with tight junction 
which, contains specific transporter molecules and vesicles. It is responsible for 
impermeability of drugs to the brain. In addition, the mammalian neurotransmitter system like 
GABA, glutamate, histamine, dopamine, noradrenalin and acetylcholine are also present in 
zebrafish. The human basal ganglia cells, the purkinje cells and the granule cell layers are 
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Figure 1: Overview of zebra fish target organ development and endpoints for toxicity screening. This 
figure is adapted from (7) 
 
Transient genes and transgenics as a toxicological method 
Injection of DNA/RNA constructs at 1-2 cell stage can lead to give transient expression of a 
gene. This allows genes to be easily visualized with fluorescent markers and can restore 
functional gene expression in mutant embryos. Transgenic lines can be used as toxicological 
method in two ways. Firstly, once a specific gene has been identified either as a marker for 
specific tissue or essential part of development pathway, these genes can be assessed for 
disruption after a chemical exposure. Secondly when a gene has disrupted gene expression or 
morphology, recovery of normal gene expression can be assessed after application of 
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therapeutic agents of morpholinos. For example transgenic zebrafish have been used to 
identify 2,3,7,8-tetrachlorodibenzo-p-dioxin(TCCD) induced neurotoxicity via changes in 
sonic hedgehog and neurogenic expression in the zebra fish brain (8). 
 
 
1.4. Eye and CNS physiology 
Zebrafish is a good model for investigation of eye development and disease because of its 
similarity to human eyes. Both zebrafish and humans have evolved eyes for diurnal life 
including cone-dense retinas, which are also biochemically more similar to human retinas. For 
example, guanylate cyclase activator 1a is expressed in zebrafish and human retinas (7, 16) 
 
The eye develops from no less than three distinct embryological tissues, neuroectoderm 
which gives rise to the neural retina, pigmented epithelium, optic stalk and ciliary margin; 
skin ectoderm, which is induced to form the lens and subsequently the cornea; and head 
mesenchyme of neural crest cell origin that minimally forms connective tissue of the cornea 
and sclera (17). 
 
The retina contains three nuclear layers and two plexiform layers. The outer plexiform layer 
contains cellbodies of photoreceptors. The inner plexiform layer contain cell bodies of 
horizontal, bipolar and amacrine cells, in addition to the ganglion layers which contain the 
ganglion cell bodies. 
The plexiform layers are found between the nuclear layers and are where the synaptic 




Figure 2: Description of zebrafish retina physiology.On the right (B) Radial cryosection of zebrafish retina, 
showing retinal pigmented epithelium (rpe), outer and inner segments of photoreceptors (os/is), outer nuclear 
layer (onl) containing photoreceptor nuclei, outer plexiform layer (opl), inner nuclear layer (inl), inner plexiform 
layer (ipl), ganglion cell layer (gcl), and nerve fiber layer (nfl). This figure is borrowed from (19) 
 
 
During 24 hours to 48hpf of embryo development, the zebrafish eye undergoes proliferative 
changes where the ganglion layers overlaps the inner nuclear cells, then the outer layer of the 
photoreceptors (20). 
The first cells to differentiate in the zebra fish retina are the ganglion cells (~32 hpf) along the 
vitreal border, followed by the appearance of an inner plexiform layer and amacrine cells. 
Formation of the photoreceptor layer follows that of inner retinal neurons, at approximately 
48 hpf (21). 
 
Transcription factors that are available in the eye are Pax6 which is present in all cells that 
form the neural retina, lens epithelium and pigment epithelium, whereas Pax2 which is 
primarily responsible for the cells of the optic stalk.  
The absence of these transcription factors can lead to small eye/ectopic eye structures in zebra 











A variety of intrinsic factors have been demonstrated to influence Pax6 during retinogenesis 
(23). 
 
Figure 3: Intrinsic factors that influence retina development. The surface ectoderm (SE) is responsible for 
the secretion of the FGFs (blue arrows) which promote the neuroretina (NR) differentiation while while a 
transforming growth factor β (TGFβ) family member secreted from the mesenchyme (yellow arrows) is a 
candidate for promoting retina pigmented epithelium RPE cell fate. Finally sonic hedgehog (Shh) emanating 
from the ventral forebrain (red arrows) promotes formation of the optic stalk from the ventral portion of the optic 
vesicle OV. The initial patterning of the optic vesicle to distal Neuroretina (NR) and proximal retina pigmented 
epithelium domains is mediated by the head surface ectoderm (SE) and surrounding mesenchyme. This figure is 
adapted from (23) 
 
 
Central nervous system 
The central nervous system starts to develop after 6hpf during the grastulation stage. The 
neural plate is formed which is converted to neural tube during 9-10 hpf. After the 
grastulation stage during 24 hpf the CNS is subdivided into several parts including the 
forebrain (telencephalon and diencephalon), the midbrain, the hindbrain and the spinal cord. 
At 48 hpf the embryo starts to develop touch stimuli. And during 72 hpf the embryo is fully 




Alcohol is a widely consumed substance worldwide. Prenatal alcohol exposure can lead to 
Fetal Alcohol syndrome (FAS) in humans and alcohol-mediated development toxicity in 
zebra fish embryos causing fetal development disorder like mental retardation, growth delay, 
face abnormalities including small eyes and apoptosis within the developing nervous system. 
Children with FAS show a variety of ophthalmic defects ranging from microphthalmia, 
coloboma of iris, optic nerve hypoplasia, and visual impairment, to minor anomalies such as 
strabismus. Retinal function is known to be affected by prenatal ethanol exposure (21). 
 
Nationwide, FAS occurs has an estimated prevalence 8 for every 1,000 child births (24). 
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During embryogenesis intake of alcohol can result into birth of children with a smaller brain 
size and thinner cerebral cortex. Ethanol interferes with ontogenic phases of brain 
development affecting crucial processes like neurogenesis, neuronal migration, apoptosis and 
gliogenesis (25). 
 
Lower concentrations or shorter durations of alcohol exposure can lead to alcohol related 
birth defects (ARBD) or alcohol related neurodevelopment disorder (ARND) (26)  
National Organization on Fetal Alcohol Spectrum (NOFAS) in 2004 agreed to use the term 
Fetal Alcohol Disorder as a supportive expression, not as a diagnostic category but to 
incorporate various others diagnostic categories such as FAS, ARBD and ARND (27). 
 
Zebrafish share many similar cellular and physiological characteristics with mammals thereby 
they provide an excellent vertebrate model system. 
 
During embryogenesis alcohol is permeable through the chorion which makes it simpler and 
precise for the alcohol delivery.1/25
th
 of the external concentration of alcohol can immerse 
through the eggs (28). Embryos can be placed and removed from alcohol at different times 
which makes it easier to control the alcohol concentrations and time for exposure (29). 
 
In humans it is difficult to control the participants and determining alcohol dose by taking 
blood tests, which might be stressful for the mother and the fetus.  
The disadvantage of using zebrafish instead of humans is that zebrafish eggs are developed 
and fertilized externally where as human are maternal (28), which makes it complex to 
compare the physiology. The lack of a placenta, which might offer some protection for the 
developing organism in mammals, is one of the most important. In fact, this relies on a 
completely different way of exposure to the drug (direct versus indirect), and reflects potential 
differences in drug adsorption, distribution, metabolism and activation capacity in the 
zebrafish compared to mammals (30), however the external development of the embryos 
makes it possible for changes in development to be observed in detail without sacrificing  the 
maternal component and it removes the complication of maternal/placental fetal interaction 
(11). Another thing is lack of knowledge about the development stages of zebrafish and their 
correlation to stages of human brain development. However the embryonic development of 
the brain is well known (29). 
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Alcohol toxicity in zebrafish has not been used as a primary focus for investigation but it has 
been used as a blunt intsrument to pertube a particular development or signaling way of 
interest. Thereupon Zebrafish emrbyos have been used to study how alcohol influences 
different gene expressions (31). 
 
The pathological features of alcohol-mediated toxicity in zebrafish embryos include cognitive 
defects, delayed cell differentiation, reduced body length, abnormal development of the eye 
(micropthalmia, cyclopia), neuronal cell death, craniofacial malformation, behavioral 
impairment (shoaling) and increased mortality (32). 
 










1.6.  Possible targets for ethanol mediated toxicity 
Ethanol affects the GABAergic and GLUTAergic neurons in the CNS by disrupting sonic 
hedgehog (Shh), fibroblast Growth Factors (fgf 19), fgf3, fgf8 and Atohnal expressions (33). 
 
When ethanol is consumed at early stages of pregnancy, it can affect the GABA-induced 
activity on the excitatory activity in immature neurons which indirectly increases intracellular 
Calcium, a process that could contribute to a normal brain development, circuit formation 
during neurogenesis, synaptogenesis, differentiation and migration (34). 
 
Sonic hedgehog plays and important role in regulating vertebrates’ organogenesis such as 
growth of digits and the brain. The hedgehog family consists of Sonic hedgehog (Shh), Desert 
hedgehog (Dhh) and Indian hedgehog (Ihh). The Sonic hedgehog signal pathway is the one 
that is most studied (35). 
Shh is a signaling system, which is also expressed in the midline of the central nervous 
system. It regulates the eye development and is crucial for the separation of the eye fields, 
formation of the optic stalk, dorsal-ventral patterning of the retina, differentiation of both 
neural retina and pigment epithelium and the normal laminal organization of the retina (36). It 
is also said to be the key target for prenatal ethanol exposure. 
Expression of Sonic hedgehog control the neurogenesis by amacrine cells, it appears to 
mediate specification of the other retinal neurons and to differentiate the post-mitotic cells 
between 28 and 32 hpf (17). 
 
To date there are 22 Fibroblast growth factor ligands in vertebrates which activate 
transmembrane receptor kinase at the cell surface. This signaling activates the small GTPase 
Ras and several cascades mostly the MAP kinase cascade (through Ras, the serine/threonine 
kinase RAF and the MAP/ERK kinase MEK). This activation can lead to specific 
phosphorylation and activation of the key transcription factors (37). 
 
Fibroblast growth factor is needed for the correct forebrain patterning (in the anterior neural 
border dorsal teleencephalon and the diencephalon). Fgf3 and Fgf8 changes quickly in the 
developing forebrain, they are implicated in telencephalic and diencephalic ventral patterning, 
and their loss of function leads to defects in neuronal differentiation. Fgf8 is responsible for 
the teleencephalon, midbrain and cerebellum while Fgf3 is expressed in the forebrain and the 
hindbrain. Fgf3 and Fgf8 are implicated in the regional patterning of the brain where Fgf8 
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regulates its own transcription and the transcription of Fgf3 in the forebrain. Fgf19 is also 
critical for the development of the ventral region of the telencephalon and diencephalon and is 
implicated in the specification of γ-aminobutyric acid (GABA)ergic interneurons and 
oligodendrocytes in the telencephalon and diencephalon (38). 
The expression of Shh seems to be dependent on the signaling by Fgf3 and Fgf8 on the 
hypothalamus and the forebrain, it is said they have an intimate relationship and a positive 
feedback loop (37). 
 
Heparan Sulfate proteoglycan (HSPGs) are cell surface and extracellular matrix protein that 
mediate a diverse range of crucial functions during vertebrate and invertebrate development. 
These functions include regulation of cell growth and differentiation of axon outgrowth in the 
developing CNS. HSPGs also modulate Fgf-mediated axon growth in the retinotectal system. 
Agrin is a HSPG that was initially discovered and characterized functionally based on it 
essential role in neuromuscular synapotogenesis. Agrin is expressed by spinal cord, motor 
neurons and skeletal muscle, as well as other neural and non-neural tissues that include lung, 
kidney, brain and eye. Agrin is essential for retina development and it’s characterized by its 
neurogeneal synaptogenesis.  
Agrin is needed for the correct Shh signaling for eye development. Since prenatal ethanol 
exposure can lead to agrin knockdowns in eye development this can lead to problems with 
optic nerve formation probably due to the fact that agrin modulates Fgf mediated axon 
outgrowth on retinal ganglion axons. In addition fgf2 mediated formation of the Xenopus 
retinotectal pathway is also HSPG dependent. Agrin knockdowns lead to impaired Midbrain 
Hindbrain Boundary formation (39). 
 
Agrin and Fgf are important for the optic nerve growth and eye development. Several studies 
show that Pax6 and ath5 is perturbed after agrin knockdown in zebrafish embryos (40). 
 
Several studies have shown that both purkinje cells and external granule cell is reduced by 






Figure 5: Description of granule cell development in amniotes:Granule cell precursors (red) are initially 
induced at the rhombic lip by TGFβ signals (green) from the adjacent roofplate (i). Precursors migrate 
tangentially over the sub-pial cerebellar surface and divide again within the transient EGL (ii). Proliferation is 
regulated by Shh secreted from underlying Purkinje cells (purple). After their last cell division, postmitotic 
granule cells (brown) radially migrate into a layer below Purkinje cells (iii). In the mature circuit, glutamatergic 
granule cells receive inputs from precerebellar neurons and project T-shaped axons (parallel fibres) into an 
almost cell body-free (molecular) layer, where they synapse on the dendrites of GABAergic Purkinje cells. 
Purkinje cell outputs directly and indirectly regulate the activity of the vestibular system, thalamus and sub-
cortical motor centres (41). 
 
 
These are possible targets for the ethanol effects on neuron development of zebrafish embryo. 
Raising the possibility that ethanol-mediated reduces in forebrain Fgf gene expressions may 













1.7.  Pax6 and Pax2 roles in ethanol mediated toxicity 
Pax genes comes from a family of 9 evolutionary conserved transcription factors (Pax1-Pax9) 
and is divided into four subgroups based on similarities in structural domains (paired domain, 
homeo-domain and octapeptides) whereas paired domain and homeo-domain recognizes a 
specific DNA sequence (42). 
 
Pax6 and Pax2 are transcription factors that are extremely important in the development of 
the zebra fish embryo eye and the brain.  
 
Pax6 was initially cloned from human, mice, zebrafish and quail. The Dorsophila eyeless 
gene was shown to be a Pax6 homolog and Pax6 homologs have now been described in other 
invertebrates such as flatworm, ribbonworm, C.elegans, squid, sea urchin and ascidian. 
Pax6 is expressed from the earliest stages of eye morphogenesis in the optic vesicle, giving 
rise to the retina and pigment retina, as well as in the overlying ectoderm that later forms the 
lens and the cornea. However, Pax6 is also expressed in the nasal epithelium, in specific 
regions of the brain and the spinal cord, and not exclusively in eye primordial (43). 
Pax6 is said to be the key regulator of eye development. Over-expression of Pax6 in mice 
results to a severe eye phenotype called small eye, whereas reduction of Pax6 activity in 
humans results to aniridia (43). 
Ethanol can reduce proliferation and neuronal differentiation radial glial cells through 
decrease of Pax6 transcription factor. Pax6 is a target of several signaling pathways, and 
phosphorylation sites for p38, ERK and homeo-domain interacting protein kinase 2 are 
identified (44, 45). 
 
Due to a duplication of the teleost genome million years ago, there are two copies of  
Pax6 and Pax2 genes in zebrafish. Pax6 genes in zebrafish  are divided into Pax6.1 and 
Pax6.2 whereby Pax6.2 is said to show stronger transactivating capability than Pax6.1 and 
both genes are said to induce ectopic eye structure, Where by Pax2 is divided into Pax2.1 and 
Pax2.2 (46).  
Pax2.1, which is expressed in the junction between the forebrain and hindbrain, also called 
midbrain (isthmus) decides the fate of development of the other parts of the brain during 
grastula stage. It is also expressed in the CNS, in the developing eye, ear and the kidney (47). 
Pax2.1 is localized at the midbrain-hindbrain border and is usually recognized by a stripe 
(furrow separating the midbrain and the hindbrain). Zebrafish Pax2 probe can detect this at 
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very early stage of embryo development, at later stages of embryo development the tectal 
ventricle enlarges, the tissue between the furrow separating the midbrain and the hindbrain 
gets considerably thinner (48). 
Midbrain-hindbrain boundary (MHB) is a signaling center, acting to pattern and establish 
neural identities within the brain. MHB originally identified in chick consists of cells that 
influence the fate of neighboring cells to adopt either a mesencephalic (midbrain) or 
metaencephalic (hindbrain) fate through expression of transcription factors and soluble 
signaling molecules. A cascade of signaling (Fgf8) and transcription (Pax2/5/8, eng 1/2) 
factors within Otx2/Gbx1/2 boundary induces formation of the MHB and subsequent 
interplay between these factors is critical for maintenance of the MHB. Disturbance of any of 
these factors lead to severe functional disruption in the formation of the isthmic organizer 
(49). 
It’s only seen through the first 48hrs of development and then fuses with the forebrain. Loss 
of the midbrain identity can cause expansion of the forebrain territory and hindbrain territory 
(50). 



















2. AIM OF THIS THESIS 
 
The aim with the thesis was to see if zebrafish embryos can be used to study the effect of 
ethanol on early brain development. This was done by:  
1. Generation of tools for the study of specific parts of the brain, zAtoh1a1, zAtoh1a2 and 
zAtohlc genes which are expressed in the cerebellum will be isolated from zebrafish cDNA 
and cloned to be used for in situ hybridisation . 
 
2. Incubation of zebrafish embryos with different concentrations of ethanol to look for changes 
in overall morphology and survival. Studies on the molecular level, including in situ 





































E3 medium had a pH between 6.8-6.9 and contains: 
 5mM NaCl 
 0.17mM KCl 
 0.33 mM CaCl2 
 0.33 mM MgSO4 
 0.00001% w/v methylene blue 
 
S.O.C Medium  
 2 % Tryptone  
 0.5 % Yeast Extract  
 10 mM NaCl  
 2.5 mM KCl  
 10 mM MgCl2  
 10 mM MgSO4  



















Table 1: Materials used 
Glyserol Catalog no: 49782-1L Sigma Aldrich 
Tween 20 Catalog no: P1379-500ml Sigma Aldrich 
Magic marker Catalog no: LC5602 Novex 
Sea blue Plus 2 prestained Catalog no: LC5925 Novex 
Protinase K 20mg/ml Catalog no : 25530-049 Invitrogen 
NCB/BCIT Catalog no: 11697471001 Roche 
Anti-Digoxigein Fab fragments Catalog no : 11093274910 Roche 
Ethanol absolute Catalog no : 322221 Sigma Aldrich 
Methanol Catalog no : 32213-K Sigma Aldrich 
Sea kem
®
Agarose Catalog no : 50004 Loriza 
Blocking Reagent Catalog no : 1096176 Roche 
Paraformalaldehyde Catalog no : 200-001-8 Merck Schuchardt 
Formamide Catalog no: F-9037 Sigma Aldrich 
Heparin 5000U/ml Catalog no : L6510  Biochrom 
tRNA 500μg/ml Catalog no : 10109223001 Roche 
Hydrogen peroxide Catalog no : 203626 Apotekforeningen NAF 
Anti-pax6 rabbit polyclonal Catalog no : AB2237 Millipore 
Donkey anti-rabbit IR-Dye Catalog no : 92668023 Li-COR,Odyssey 
Trizol Reagent Catalog no : 15596018 Ambion 
DIG RNA labeling kit Catalog no : 11175025910 Roche 
LDS-Sample buffer(4x) Catalog no : NP0008 NUPAGE 
Reducing agent  Catalog no : NP0009 NUPAGE 
Isopropanol/2-propanol Catalog no : 59300-1L Sigma Aldrich 
Chloroform Catalog no : 1-2445-1 Merck 
PCR-Cloning kit Catalog no : L:44-0302 Invitrogen 
Qiagen Plasmid Mini-kit Catalog no: 12125 
Anti-actin Catalog no : A2066 Sigma 
Qiagen Spin Mini-prep kit Catalog no: 27106 






Biofuge Fresco Cold centrifuge 
NanoDrop ND-1000 Spectroohotometer 
Peltier Thermal Cyckler (PTC-200) DNA engine from MJ Research 
MJ Research PTC 200 Peltier Thermal Cycler block 
MJ Research PTC 200 Peltier Thermal Cycler tubes, Temperature gradient 
Stuart Block heater, SBHI30DC 
Biofuge Fresco Pico centrifuge 
Grant Broekel Blockheater 
Unitorn shaker 
MERK eurolab Hedolf UNIMAC 2010 rocking plateform 
Bioruptur sonicating machine 
Femarks heating cabinet 
3130 XL and 3530 XL Genetic analyser(ABI) 
High Performance Ultraviolet Transilluminator 


















5.1. Gel Electrophoresis  
Agarose gel 0.7 % 
This is a method used to separate the DNA, RNA and proteins fragments by length and size 
estimation. The agarose (0.7 %) is made by weighing 1.05 g Agarose and adding 150 ml  
1x TAE on a conical flask. The mixture is warmed on a microwave for about 2 minutes. The 
solution must med mixed homogenously and thoroughly in between until when it start to 
bubbles. The temperature is reduced to 60 ºC, by cooling the conical flask on running water, 
thereafter placed in a Fermarks heating cabinet. 
A sample comb and casting tray is chosen, placed on a holder. 50 μl 1 mg/ml ethydium 
bromide is placed on a gel casting tray and agarose is poured to cover the combs about 1cm 
from the tray. After the gel is solidified about 20 minutes, the comb is removed and the 
casting tray with the gel is placed on an electrophoresis chamber and is covered with the 
buffer TAE. 
The DNA samples are mixed with 6XT and applied to the wells of agarose gel 1kb plus DNA 
molecular weight standard is used as reference (Figure 6). The lid is placed on, the positive 
and negative electrode on the right spots and the current is allowed to flow. Current flow is 
set up at 90V and flow time is 30-40 minutes Bubbles appearance on the electrodes confirms 
the flow of current. 
Pictures were taken by using transilluminator which was connected to the camera and 
computer.  
 






0.25 % bromphenole blue  
60 mM Na2EDTA (pH 8.0) 
0.6 % SDS 
40 % (w/v) sucrose in water  
 
TAE (50X Stock solution) 
242 g Tris base in water, 
57.1 ml glacial acetic acid,  
100 ml of 500mM EDTA (pH 8.0) solution 
Adjust to 1 liter 
 
1 kb plus ladder 
10 mM Tris-HCl (pH 7.5)  
1 mM EDTA  
50 mM NaCl  
 
 
5.2. Isolation of RNA from zebra fish embryos 
120 embryos were placed on two eppendorf tube on ice, 60 embryos on each tube. All media 
was removed. 300 μl Trizol (Ambion) was added to two new microcentrifugetubes and 
approximately 200 μl was used in a 1ml syringe with 25G cannula. The embryos were 
homogenized by mixing them back and forth with the syringe (3X). The remaining 100 µl of 
Trizol was then used to rinse the syringe and added to the homogenized embryo’s .At this 
point the embryos could have been stored at -80 ºC. 
An additional amount of 600 μl Trizol was added to the embryos and left in room temperature 
for 5 minutes. 200 μl of Chloroform (Merck) was added and the samples were placed on ice 
for 20 minutes. The tubes were inverted several times every 2 minutes. 
The samples were then centrifuged in a cold centrifuge at 9000 rpm for 30 minutes 
The water phase on the top was transferred to another new tube (approximately 500 μl).  
500 µl of Isopropanol was added to the samples and then incubated for 10-15 minutes in 4ºC 
The samples were centrifuged at 12000 rpm at 4ºC for 30 minutes 
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The supernatant over the RNA pellet was removed and 1 ml ice cold. 80 % ethanol was added 
for washing the pellet. Centrifugation was done at 12000 rpm for 5 minutes 
The supernatant was removed and the tubes were left to dry in the hood until all ethanol had 
evaporated 
The RNA-pellet was re-suspended on 60 μl RNA-ase free water. 
The concentration of the isolated RNA was measured by using NanoDrop ND-1000 
Spectrophotometer, Saveen Werner 
 
 
5.2.1. Synthesis of cDNA 
RNA was treated with Heat & Run gDNA removal kit (Articzymes), to eliminate genomic 
DNA. 
2 μl HL-dsDNAase and 2 μl 10x Reaction buffer per 10 μl RNA was mixed with the RNA. 
Incubated at 37 ºC for 10 minutes and thereafter 55 ºC for 5 minutes. RNA was placed on ice. 
To every tube 6 μg RNA, 2 μl 0,25 μg/μl Random Hexamer Primer (pd(N)6),2 μl 10mM 
ẟNTP,and  RNAase free water was added to a total volume of 26 μl. The mixture was place 
on a blockheater (Stuart) at 65ºC for 5 minutes and then cooled on ice for minimum 1 minute. 
The samples were then centrifuged for about 5 seconds on Eppendorf minispin to collect the 
samples at the bottom. Then the following was added to each tube 8 μl 5 x First-Strand Buffer 
(Invitrogen), 2 μl 0,1M DTT (Invitrogen), 2 μl RNAase OUT Recombinant Ribonuclease 
Inhibitor (Invitrogen), and 2 μl Superscirpt III RT 
Samples were placed on a PCR-machine with a following program 
1. 25 ºC for 5 minutes 
2. 50 ºC for 55 minutes 
3. 70 ºC for 15 minutes 




PCR BLOCK GRADIENT. 
A mastermix was made containing (Total amount 60 µl) 
3 µl DNA 
24 µl H2O 
1.5 µl primer zAtoh1a.RT5 
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1.5 µl primer zAtoh1a. RT3.1 
30 µl 2X DyNAzyme 
The same procedure was done using primers. 
 zAtoh1a.RT5+ zAtoh1a.RT3.2 
 zAtoh1c.RT5+ zAtoh1c.RT3 
 
PCR reaction had a following procedure 
1. Denaturation at 94 ºC for 2 minute 
2. Denaturation at 94 ºC for 30 seconds 
3. Annealing at 56 ºC (lowest) and 60 ºC (highest) for 1 minute 
4. Elongation at 72ºC for 1 minute 
5. Returning to 2nd Stage for 34 cycles 
6. Elongation at 72 ºC for 10 minutes  
7. 4 ºC forever. 
20 µl of PCR products were mixed with 4 µl 6XT (Loading buffer) 




























5.2.3. PCR-reaction with (Phusion) 




Reverse primer T7 and Forward primer T3 were used in consideration with the research of 
DIG-marking probe. 
Reaction was set up in the following procedure  
 
 
Table 2: PCR-reaction set up 
Primer Template 
Atoh1a. FWT3+Atoh1a.RT7 zAtoh1a1 
Atoh1a. FWT3+Atoh1a2.RT7 zAtoh1a2 
Atoh1c. FWT3+Atoh1c.RT7 zAtoh1ac 
 
 10 µl 5X Phusion Buffer (Biolabs) 
 1 µl ẟNTP mix (10mm) 
 2.5 µl Forward primer (10µm) 
 2.5 µl Reverse primer (10µm) 
 2,5 µl zAtoh1a1 
 2,5 µl zAtoh1a2 
 2,5 µl zAtoh1ac 
 31 µl H2O 
 0,5 µl Phusion (Biolabs) 
Total 50 µl 
 
PCR-block was set on 98 ºC with a following program 
1. Denaturation at 98 ºC for 40 seconds 
2. Denaturation at 98 ºC for 10 seconds 
3. Annealing at 58 ºC for 20 seconds 
4. Elongation at 72 ºC for 30 seconds 
5. Returning to 2nd Stage for 29 cycles 
6. Elongation at 72 ºC for 5 minutes  
7. 4 ºC forever. 
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PCR block was first warmed up to 98 ºC, before the samples were loaded. 
PCR products were set up for gel electrophoresis for 30 minutes 





Table 3: Overview of primer sequences used. 
Name Sequence PCR-
(bp) 
zAtoh1a.RT5 5-GAACTCGACGTCCAGCATTC-3  
553 bp 
zAtoh1a.RT3.1 5-CCGTTTCTAACACGTTGGCA-3  
zAtoh1a.RT5 5-GAACTCGACGTCCAGCATTC-3  
909 bp 
zAtoh1a.RT3.2 5-GCAACCCATTACAAAGCCCA-3  
zAtog1c.RT5 5-ATGCCCCATCCGGACACCCCTTTTGG-3  
zAtog1C.RT3 5-CTATTTTACACCATTGTTCCTTTCCA-3 615 bp 




zShh.RT3.1  5-TCGCAGCAACCGAATTTTCT-3  
zAtoh1a.FWT3 5-CATTAACCCTCACTAAAGGGAAGAACTCGACGTCCAGCATTC-3  
553 bp 
zAtoh1a.RT7 5-TAATACGACTCACTATAGGGCCGTTTCTAACACGTTGGCA-3  
zAtoh1a.FWT3 5-CATTAACCCTCACTAAAGGGAAGAACTCGACGTCCAGCATTC-3  
909 bp 





















DNA cloning allows a DNA fragment with a particular nucleotide sequence to be separated 
from a complex mixture of fragments with many different sequences. 
Plasmids are circular, double-stranded DNA (dsDNA) molecules that are separate from a 
cell’s chromosomal DNA. Plasmids are actually 1.2-3 kb in length and they contain a 
replication origin, a gene that is resistance to a particular drug and exogenous DNA (promoter 
lac Z and multiple cloning site. 
Transformation of plasmid in bacteria involves uptake and expression of foreign DNA (53). 
Two different plasmids were used which are PCR
®
 blunt vector with linearized blunt ends 
(Kanamycin resistant) and pbluescript SK+/-(Ampicillin resistant). 
 
 






























cDNA was used as a template with the following primer sequence: 
 zAtoh1a.RT5+ zAtoh1a.RT3.1 
 zAtoh1a.RT5+ zAtog1a.RT3.2 
 zAtoh1c.RT5+ zAtoh1c.RT3 
Each PCR-reaction had a total volume of 40 μl with 2 μl of cDNA, 16 μl of H2O, 1 μl 
zAtoh1a.RT5 +1 μl zAtoh1a.RT3.1 and 20 μl of 2 x DyNAzyme Mastermix. The same 
procedure was repeated with other primers. 
PCR reaction had a following procedure 
1. Denaturation at 94 ºC for 2 minutes 
2. Denaturation at 94 ºC for 30 seconds 
3. Annealing at 56 ºC for 1 minute 
4. Elongation at 72 ºC for 1 minute 
5. Returning to 2nd Stage for 34 cycles 
6. Elongation at 72 ºC for 10 minutes  
7. 4ºC forever. 
10 µl of PCR products were mixed with 2 µl 6XT (Loading buffer) 
            PCR products were set up for gel electrophoresis for 30 minutes at 90V 
 
 
5.3.2. Blunt cloning of PCR-product 
Zero Blunt PCR-Cloning Kit from Invitrogen was used 
Blunt vector 1 µl 
PCR product 2 µl of each 
5X Ligase Buffer 2 µl 
H2O                      4 µl 
T4 DNA Ligase   1 µl 
Total                    10 µl 
 
The mixture was left in room temperature for 30 minutes. 2 µl of the total 10 µl mixture was 
mixed with 50 µl of DH5 Competent Bacteria cells in a 15ml Falcon tube. Mixture was left 
on ice for 1 hour. Heat shocked for 30 seconds at 42 ºC. Placed vial on ice for 90 seconds. 
250 µl of S.O.C medium was added and the mixture was placed for 1 hour at 37 ºC at  
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225 rpm (Unitorn shaker).100 µl bacteria was spread on LB plate with 50 ug/ml Kanamycin 
by using sterile bacteria techniques. Plates were left to dry and turned upside down, then 
placed at 37 ºC overnight (O/N).  
Plates were stored at 4ºC. Colonies were picked randomly from each plate with a sterile 
toothpick and placed in a 15 ml Falcon tube containing LB medium with 3 ml Kanamycin (50 
µg/ml) and incubated at 37 ºC, 225 rpm O/N 
 
 
5.3.3. Cloning with pBluescript 
pBluescript ks+/- was digest with EcoRV(Biolabs) 
7 µl of DNA, 2 µl 10xTA, 1 µl EcoRV, and 10 µl H2O was placed on a Block heater 37 C 
for 90 minutes.  
1 µl SAP ( Biotec Pharmacon) was added and the mixtures was incubated again at 37 C for 
30 minutes. 
20 µl DNA and 4 µl 6XT were set up for electrophoresis 90V for 30 minutes. 
Spin Mini-prep kit was used. The procedures were the same as in Mini-Prep (5.3.8). 
 
 
5.3.3.1. Qiagen (gel purification) 
DNA fragment from agarose gel was excised with a clean sharp scalp with help of   
UV-light. The gel slice is weighed in a colorless tube. Added 3 volumes of buffer QG to one 
volume of gel (100 mg~100 µl) QG. Incubated the mixture on a blocking heater at 50 C for 
10 minutes. Within 2-3 minutes the mixture was flipped to help dissolve the gel. Assured that 
the mixture is yellow (similar to buffer QG without dissolved agarose). The whole mixture 
was transferred to a spin column and spin for 1 minute at 13000 rpm. 
500 µl was added, spin for 1 minute at 13000 rpm, 750 µl PE was added centrifuged for 1 
minute at 13000 rpm, centrifuged for 1minute at 13000 rpm .50 µl Eluting Buffer was added 











13 µl H2O 
2 µl pBluescript (EcoRV digested, gel purified) 
2 µl PCR product (zAtoh1a, zAtoh1b, zAtoh1c) 
2 µl 5xLigation buffer 
1 µl T4 DNA-ligase 
Ligation was set up for O/N (16C)  
 
 
5.3.4. Transformation of bacteria 
Bacteria were transformed with pBluescript vector and pZero-blunt (Invitrogen). 50 µl of 
DH5 competent bacteria was placed in a 15 ml falcon tube and 2 µl of ligation mixes 
containing either pBluescript or pZero-blunt vectors were added to the bacteria. Placed on ice 
for  
30 minutes. Heat shocked for 45 seconds at 42 C, placed on ice for 2 minutes. 250 µl S.O.C 
was added at RT and the mixture was incubated for 1 hour at 37 ºC at 225 rpm (Unitorn 
shaker). 100 µl was spread on LB plates containing 100 µg/ml Ampicillin for the bacteria 
containing pBluescript plasmid, and on plates containing 50 µg/ml Kanamycin for the pZero-
blunt transformed bacteria. Plates were left to dry and turned upside down, and then placed at 
37 ºC O/N.  
Miniprep light procedure was done. 
     
5.3.5. Miniprep “light” 
1.5 ml bacteria cultures were transferred to 1.5 ml eppendorftubes. Centrifuged for  
20 seconds and supernatant removed. Pellet was re-suspended in 100 µl Buffer P1 with RNA-
ase and vortexed. 100 µl Buffer P2 was added and tubes were mixed by turning up and down 
4-6 times. Tubes were left on RT for 4 minutes. 140 µl Buffer N3 was added and tubes were 
mixed by inverting 4-6 times. Tubes were centrifuged for 10 minutes, 13000 rpm in room 
temperature (RT). Supernatant was transferred to new tubes. 400 µl isopropanol was added; 
tubes were mixed by inverting 4-6 times. Tubes were left on RT for 2-3 minutes. Tubes were 
centrifuged for 5 minutes at 13000 rpm at RT. Supernatant was discarded and the DNA-pellet 
was washed by adding 500 µl 70 % EtOH. Tubes were centrifuged for 5 minutes, 13000 rpm 
at RT. Supernatant was removed. Tubes were dried on the bench for 10-15 minutes. DNA-
pellet was dissolved in 50 µl TE. DNA was set up for gel electrophoresis (0.7 % Agarose gel): 
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 2 µl DNA for each DNA-prep tube 
 3 µl H2O 
 1 µl 6XT 
 
5.3.6. Digestion of DNA with restriction enzyme (pZero-Blunt vector) 
Mastermix was made containing: 
 28 µl 10X TA 
 7 µl EcoR I(Biolabs) 
 35 µl H2O 
Total    70 µl →5µl placed in 12 new eppendorftubes  
 
5.3.7. Digestion of DNA with restriction enzyme (pBluesccript vector) 
A mastermix with p-bluescript vector was made containing 
 28 µl 10X TA 
 7 µl EcoR I(Biolabs) 
 35 µl H2O 
 14 µl Hind III(Biolabs) 
     Total    84 µl →6µl placed in 12 new eppendorf tubes with 15 µl DNA 
15 µl DNA was placed in each tube and tubes incubated at 37 ºC for 1 hour. 
For each DNA-prep tube 4 µl 6XT was added and set up for gel electrophoresis for 40 
minutes at 90V. 
 
 
5.3.8. Mini PREP  
Approximately 100 µl from tubes containing bacteria with insert was placed in 15 ml Falcon 
tube and 3 ml LB-medium Kanamycin 50 µg/µl was added. Tubes were incubated in a shaker 
225 rpm O/N at 37ºC. 1,4ml of the overnight cultures were centrifuged at 4000 rpm for  
2 minutes in eppendorftubes. 250 µl Buffer P1 with RNAase cold from (Qiagen Kit) was 
added and vortexed. 250 µl Buffer P2 was added and tubes were mixed by inverting 4-6 times 
left for maximum 5 minutes. 350 µl Buffer N3 was added and tubes were mixed inverting 4-6 
times. Tubes were centrifuged for 10 minutes at 13000 rpm 
Supernatant was transferred to a spin column. Spin Column was centrifuged for 1 minute at 
13000 rpm 




Supernatant was removed and 750 µl PE Buffer was added and centrifuged for 1 minute at 
13000 rpm. Supernatant was discarded and the spin column centrifuged for 1 minute at  
13000 rpm 
Colon was placed in 1.5 ml eppendorf tube. 50 µl Elution buffer was added, left to rest for  
1 minute. Colon was centrifuged at 13000 rpm for 1 minute 
 
DNA was set up for gel electrophoresis (0.7 % Agarose gel): 
 2 µl DNA for each DNA-prep tube 
 3 µl H2O 
 1 µl 6XT 
 
 
5.3.9. Sequencing for (pZero-blunt) 
Two tests were done on each group marked 1a, 4a, 5b, 7b, 11c and 12c. 
The same procedure as for miniprep (5.3.8) was done to cleanse the minipreps for sequencing. 
Measured the DNA by using by using NanoDrop ND-1000 Spectrophotometer,Saveen 
Werner 
A sequence reaction was set up for 1a, 5b and 12c using PCR-products, Big dye, M13R 
primer, Sequencing buffer and H2O 
(A=zAtoh1a1, B=zAtoh1a2, C=zAtoh1c) 
 
Table 4: Measurements of DNA 
 1a 4a 5b 7b 11c 12c 
260/280 1,84 1,86 1,86 1,86 1,86 1,85 
260/230 1,93 1,94 2,08 1,92 1,44 1,92 






















A following sequencing program was set up 
1. Denaturation at 94 ºC for 1 minute 
2. Denaturation at 94 ºC for 1 minute 
3. Annealing at 63 ºC for 2 minutes 
4. Elongation at 72 ºC for 2 minutes 
5. Returning to 2nd Stage for 35 cycles 
6. Elongation at 72 ºC for 10 minutes  
7. 4 ºC forever. 
The sequence reaction was then sent for sequencing at the medicine department. 
A tool method called BLAST (Basic Local Alignment Search Tool, 
http://www.ncbi.nlm.gov/BLAST) was used to search if the zebra fish genomic DNA was 
conclusive as expected. 
5.3.10. A new miniprep “light “ was done using zAtoh1c in pZero-blunt and PCR2.1 













 1a 5b 12c 
DNA 3 µl 4 µl 4 µl 
Sequencing buffer 4 µl 4 µl 4 µl 
M13 R primer 1 µl 1 µl 1 µl 
Big dye 2 µl 2 µl 2 µl 
H2O 10 µl 9 µl 9 µl 
Total 20 µl 20 µl 20 µl 
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5.4.  ZEBRAFISH HUSBANDRY 
5.4.1. Mating 
Zebrafish are stored in a fish laboratory in containers marked with date of birth and when 
lastly spawned. The tank system used is called Zeb Tec which changes the water continuously 
and maintains the right temperature on the osmotic water, pH and conductivity. The 
maintenance temperature is about 28 ± 0 ºC, pH of 7-8 (6). 
The adult zebrafish are fed with Artemia (adult brine shrimp) two times per day and Gemma-
Micro 300 (Skretting) three times per day. 
The female zebra fish has a round bottom while the male zebra fish is more slender, 
streamlined and darker in color. The male fish has reddish-yellow hue around the blue stripes 




Figure 10: A: Male ZF, B: Female ZF. Female zebrafish has a round bottom while the male is more slender. 
The male zebrafish has a yellowish-hue around the blue stripes while the female alternate with silver stripes 
along the blue stripes (58)  
 
 
Reproduction usually occurred during the photoperiod at the first few hours of daylight from 
08:45 am where by the separated females and males are combined. 
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The female zebra fish were separated from the male fish during the afternoon 15 p.m (the day 
before spawning .The main reason for separating them is to prepare them for fertilization. 
Oviposition is divided into three parts the initiatory, receptive and spawning. The release of 
gluconorides in the water induces ovulation for the females. During the initiatory phase the 
males swim towards the female and touch their tails with their noses/head, circling around the 
females or in front of them, at this phase the females swim beside the males. During spawning 
the females release hormones that tempt male mating behavior (6).The females swims besides 
the males in such a manner that their genital pores are aligned to each other, where the male 
performs tail oscillations around the females triggering oviposition and simultaneously 
releasing sperms. Typically 5-20 eggs are released at a time (57). 
Several methods were used during mating including marble technique, where by marbles 
were placed at the bottom of special breeding tanks. When fish spawn over the marbles, the 
eggs drops into the spaces in between and preventing eggs cannibalism (6). 
There could be a possibility that the fish could be squeezed in between the marbles thereby 
the marbles were replaced by artificial green seaweeds and a dark layered cover was placed 
under the tank. 
 
A special breeding tank (8L) is filled with osmotic water and a small plastic mating cage with 
a mesh bottom is placed inside the breeding tank. Fish pairs approximately 2 females and 2 
males are placed in the mating box during the afternoon. The females are separated from the 
males with a wall in between the cage. The wall is then removed during the first hours of 
daylight (photoperiod). 
 
These methods may be effective in some extent but cannot be used in production of large 
quantity of eggs. 
 
A method used in large breeding is a 70 liters tank is pawn with a net (separator) in between 
where by separating the female from the male with equal quantity during the evening. And the 
fish pairs are combined during the first few hours of daylight and left to spawn for almost 2 
hours. When the fish spawn the fertilized eggs fall through the floor of the container and 
beneath them there is another net protecting the eggs from cannibalism by adults. The fish 




The large tank has a tap where when opened and the water runs through and the eggs falls 
throughout the net filter placed under the tap .A rod is usually used to stir up the water so as 
the eggs that fastens on the bottom of the container are mixed up with the water that flows 






Figure 11: Ispawn (Zebtec) breeding tank 
  
After spawning the eggs are usually collected and cleaned using E3 medium and thereafter 
kept in E3 medium for further use. 
  
5.4.2. Quality of embryos 
The quality of the embryos was checked by observing them on the microscope. Discoloration 
of embryos to whitish precipitation was an indication that the embryos were dead. 
 
Figure 12: Description of quality of embryos, A-Dead zebrafish embryo, B: Unfertilized embryo and C: 
Fertilized embryo. 
 
The embryos that were unfertilized were recognized by lack of development. 
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Incubation of embryos in different concentration of alcohol 
99.8% of Ethanol absolute was diluted to 1 % and 2 % with Embryo medium to 50 ml  
1 % Ethanol 
C1V1 = C2V2 
99.8 % * V1= 1 %* 50000 µl 
V1 =505 µl (Ethanol absolute) and then diluted to 50 ml with E3-Medium 
 
2 % Ethanol 
C1V1 = C2V2 
99.8 % * V1= 2 %* 50000 µl 
V1 =1010 µl (Ethanol absolute) and then diluted to 50 ml with E3-Medium 
 
Dilution from 1 % Ethanol 
0.1 % Ethanol 
C1V1 = C2V2 
1 % * V1= 0.1 %* 50000 µl 
V1 =5000 µl (Ethanol absolute) and then diluted to 50 ml with E3-Medium 
Dilution from 0.1 % Ethanol 
 
0.01% Ethanol 
C1V1 = C2V2 
0.1 % * V1= 0.01 %* 50000  µl 
V1 =5000 µl (Ethanol absolute) and then diluted to 50 ml with E3-Medium 
 
 
Embryos were incubated in a 6 well petridish with approximately 20 embryos in each plate 
that contained different concentrations of ethanol. The number of embryos incubated varied 
from experiment to experiment. The well plates used were marked with the time of incubation 








Two different methods were used for dechorionisation the fish embryos. One of them is 
manually by using two needles 25G and trying to remove the chorions from the embryos by 
making a tear on the chorion with one syringe and removing the chorions with the other 
syringe (59). 
The second method used was by treating the embryos with a dilute solution of pronase 
 (2 mg/ml in E3-medium). Pronase makes the chorions brittle and easier to remove. The 
reaction was stopped by removing the pronase and washing the embryos as soon as the first 
embryo stars to come out of the chorions. The pronase treated embryos were washed up with 
E3-medium at least 3-4 times to remove the entire enzyme (3). 
 
 
5.5. DIG-labeling of probes for in situ hybridisation. 
5.5.1. Restriction enzyme digest for linearization of plasmid 
 
1. 2.5 µg plasmid was linearized with a correct restrictions enzyme 
Table 6: Set up for enzyme digestion for linearization of plasmid 
Pax 6.1 Pax 2.1 
327.6 ng/µl plasmid 412 ng/ µl plasmid 
5 µl 10x TA 5 µl 10x TA 
2 µl enzyme 2 µl enzyme 
35 µl H2O 37 µl H2O 
50 µl 50 µl 
2. Plasmid was digested at 37 ºC for 3-5 hours  
3. The products were set up for Gel electrophoresis: 5 µl plasmid DNA + 1 µl 6XT 
4. The DNA was correct so the further procedures were proceeded  
 
 
5.5.2. Cleaning and precipitation of DNA 
45 µl of cut plasmid DNA was with 155 µl H2O and 200 µl Phenol: Chloroform. The tubes 
were vortexed and centrifuged at 13000 rpm for 1 minute. The upper phase was transferred to 
two new eppendorf tubes. 200 µl of phenol:chloroform was added and vortexed, then 
centrifuged at 13000 rpm for 1 minute. The top phase was removed once again to new tubes. 
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20 µl 3mM NaOAc and 450 µl of 100% Ethanol absolute was added and vortex, then left at -
20 ºC for 1 hour. The tubes were centrifuged in a Cold centrifuge 13000rpm 4 ºC for 30 
minutes. Supernatant was removed and DNA pellet washed in 500 µl ice cold 80 % Ethanol. 
The mixtures were centrifuged again for 15 minutes at 13000 rpm at 4 ºC. DNA pellet was 
left to air dry on the bench for 10 minutes. 
 
 
5.5.3. DIG-labeling of Pax6.1 and Pax2.1 Probe 
Pellet was re-suspended  in 13 µl nuclease free H2O and the following was added: 
2 µl 10x Transcription buffer (Roche) 
2 µl DIG labeling mix (Roche) 
1 µl RNA-se inhibitor 
2 µl T7 polymerase 
The mixture was then incubated for 2 hours at 37 ºC. 2 µl 0,5M EDTA, 1 µl glycogen (20 
mg/ml), 2 µl 4M LiCl, 66 µl 100 % EtOH was added, the mixture was mixed thoroughly and 
then stored over night at -75 ºC. 
The tubes were centrifuged for 30 minutes at 13000 rpm at 4 ºC. Then washed in 300 µl 70 % 
ice cold EtOH, centrifuged for 15 minutes at 13000 rpm at 4 ºC. Left to air dry in the RNA-
hood. Then diluted in 20 µl DEPC H2O. 
1 µl probe was mixed with 4 µl DEPC H2O then warmed at 80 ºC for 10 minutes. 1 µl 6XT 
was added and the samples were run on agarose gel. Gel tub was washed with RNA ZAP. 
1 x TAE buffer was used, 80V for 30 minutes  
 
5.5.4. DIG LABELING of zAtoh1a1, zAtoh1a2, zAtoh1c 
PCR products from zAtoh1a1, zAtoh1a2 and zAtoh1ac generated from probes containing SP6 
(reverse) and T7 (forward) sites were used for DIG labeling with T7 polymerase. After 
purification of PCR products using PCR purification kit from Qiagen. The DIG labeling 







5.6. SPOT ASSAY TESTING 
The Control sample from DIG-labeling kit was diluted to 20 ng/ µl 
DIG-labeled Samples (Pax2.1 and Pax6.1) were diluted (50x) by adding 2 µl DIG-labeled 
RNA to 98 µl nuclease free H2O 
The following dilution series were made 
Table 7: Dilution series  
CONTROL A B C D E F 
Pax2.1 A1 B1 C1 D1 E1 F1 
Pax6.1 A2 B2 C2 D2 E2 F2 
 
A: 2 µl of 20 ng/ µl in 38 µl DEPC H2O …………………..1 ng/ µl 
B: 5 µl of dilution A in 45 µl DEPC H2O………………….100 pg/ µl 
C: 5 µl of dilution B in 45 µl DEPC H2O………………….10 pg/ µl 
D: 5 µl of dilution C in 45 µl DEPC H2O………………….1 pg/ µl 
E: 5 µl of dilution D in 45 µl DEPC H2O…………………..0.1 pg/ µl 
F: 5 µl of dilution E in 45 µl DEPC H2O…………………...0.01 pg/ µl 
 
1 µl of the diluted probe and Control test (A-F) were spotted in a membrane with the control 
reference on the bottom row. Thereafter crosslinked by being exposed to UV-LIGHT for 
 10 minutes. 
The membrane was then washed in washing buffer in a 10 cm petridish. Thereafter incubated 
with blocking solution for 30 minutes at room temperature, sat at a rocking plate form at  
33 rpm. Membrane was incubated in anti-DIG-alkaline phosphatase for 30 minutes in room 
temperature, rocked at 33 rpm. Ratio of 1:2000 was used since a blocking solution at 10 ml 
made.5 µl of DIG-alkaline phosphatase was added and diluted in a 1 x MAB buffer. 
Membrane was washed with washing buffer (2 x 15 minutes) and rocked at 33rpm.  
Washing buffer was removed and staining detection buffer was added for 2 minutes. 5 ml of 
staining buffer was mixed with ½ a tablet NBT/ NBCI (Roche) which was packed in 
aluminum foil to protect from the light. The staining solution was then added and the 
membrane was packed with foil and left for 15-30 minutes. 







Blocking solution (10 %) 
1 g Blocking reagent (Roche) 
10 ml MAB-buffer 
 
 
5.7.  In situ RNA hybridization (SARS PROTOCOLL) 
24 hpf, 48 hpf and 72 hpf embryos (approximately 80 embryos per tube) were used 
1. Embryos of the correct developmental stage were fixed in 1 ml 4 % 
paraformaldehyde-PBS over night at 4 ºC 
2. Dehydrated in 1 ml methanol for 10 minutes at RT, again in methanol at -20 ºC. The 
embryos could be stored at -20 ºC for several months. 
3. Rehydrated in the following procedure 
 75  % methanol/ 25 % PBS for 5 minutes 
 50  % methanol/ 50 % PBS for 5 minutes 
 25 % methanol/ 75 % PBS for 5 minutes 
 PBST for 5 minutes 
4. Optional bleaching was done on embryos >48hpf.Approximately 1 ml of bleaching 
solution was placed in tubes that contained the embryos. The tubes were then exposed 
to light so as the bleaching reaction can take place. The embryos were observed in 
between to make sure that they don’t over bleach. The reaction time wasn’t supposed 
to exceed 30 minutes. 
5. Digestion: 1 ml 10 µg/ml Proteinase K for embryos < 48hpf was used and incubated 
for 10 minutes at RT, 25 ug/ml for embryos >48hpf 
6. Reaction was stopped by rinse twice in 2 mg/ml Glycine in PBST 
7. Embryos were prefixed with 4% paraformaldehyde for 20 minutes at RT 
8. Rinsed 5 x 5 minutes in PBST 
9. Prehybridization: 
 500 µl hybridization buffer was inserted carefully when embryos sank to the 
bottom. 
 Replaced with fresh hybridization buffer and incubated at 65 ºC for 10 
minutes. 
 Replaced hybridization buffer and incubated for 3 hours at 65 ºC. 
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10. 10 µg Pax2.1 probe and 20 µg Pax6.1 probe per 6.5 ml Hybridization solution was 
warmed up for 5minutes at 70 ºC before use to denature. Embryos were incubated 
with the DIG-probes O/N at 65 ºC. 
11. Washing: All the solutions used were warmed up in net wells (65 ºC) 
 75 % formamide, 2 x SSC  for 10 minutes 
 50 % formamide, 2 x SSC  for 10 minutes 
 25 % formamide, 2x SSC  for 10 minutes 
 2X SSC for 10 minutes 
 0,2X SSC for 2x30 minutes 
12. Blocking: Hybridized embryos were transferred to wells and incubated in 
 1 ml MAB for 5 minutes 
 1 ml MAB+BMB for 1 hour 
 500 µl MAB+BMB+HI-FCS for 3 hours 
3 µl antibody (Anti-Digoxigenin-AP Fab Fragments Roche) was added in a tube marked 
“AB” with control embryos .Thereafter  600 µl MAB+BMB+LS was added  to make a 
dilution of 1:2000 and  rocked  to preabsorb while embryos are blocking.  
720 µl MAB+BMB+LS was added in each tube then 80 µl of “AB” and incubated while 
rocking O/N at 4 ºC  
13. Washing: Embryos were washed with MAB(5X 20minutes) 
 Then 3 x 5 minutes with alkaline phosphatase buffer solution 
 Transferred to 24 well dish 
14. Stained: ½ a tablet NBT/BCIP was dissolved in 5 ml MAB-solution and 800 µl was 
transferred to each well. The 24 well dishes was covered with aluminum foil and 
checked regularly for staining. Typically the staining is stopped after 2 hours but for 
some experiments the staining was prolonged O/N at 4 ºC. 
15. Staining was stopped by rinsing twice in PBST and then fixing with 4 % PFA O/N at 
4 ºC 
16. To take pictures embryos were rinsed in 25 % Glycerol for 10 minutes, 50 % glycerol 
for 10 minutes and the 100 % Glycerol (Sigma Aldrich) for 10 minutes  
17. A microscope slide was used, three layer of tape were placed on the ends of each slide 
cut 1 cm x 2 cm. Several drops of glycerol were placed in the middle and the embryo 
was placed on the middle. Cover slip was placed on top and pictures were taken by 
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using Nikon camera. Cover slip was moved back and forth to make any adjustments 
while positioning the embryo for the right posture (lateral or dorsal) 
Buffers used 
PFA 
4 % paraformaldehyde 
0.8 g PFA (Merk Schuchardt) 
16 ml H2O 
2 ml 10 x PBS 
1-2 drops (50-100 μl) 2M NaOH 
Adjusted the volume to 20 ml. 
Place on a waterbath at 65 ºC for 20-30 minutes, shaked in between. 
 
20X SSC 
175.3 g of NaCl  
88.2 g of Sodium Citrate   
800 ml H2O. 
Adjust the pH to 7.0 with a few drops HCl. 
Adjust the volume to 1 liter with ultrapure water. 
Sterilize by autoclaving. 
 
Optional bleaching (10ml) 
2.5 % 20 x SSC 
5 % Formamide (Sigma Aldrich) 
92.5 %, 10 % H2O2 (NAF) 
 
MAB 
100 mM Maleic acid  
150 mM NaCl  
pH adjusted 7.5 
0.1 % Tween 20 
 
MAB+BMB (2 % Boehringer Blocking Reagent) 
Block (dilute 5x from a 10 % stock solution)  





MAB+BMB+20 % HI-FCS (Heat indicated Fetal Calf serum) 
2 % Blocking solution (10 %) 
20 % HI-FCS 
in 1 x MAB 
 
Hybridization buffer 
50 % Formamide 
5X SSC 
50 μg/ml Heparin (Biochrom) 
500 μg/ml tRNA (Roche) 
0.1 % Tween-20 
92 μl of 1M Citric acid (pH 6,0) 
H2O to 10 ml 
 
Alkaline phosphatase buffer 
100 mM TrisHCL pH 9.5 
50 mM MgCl2 
100 mM NaCl 
0.2 % Tween-20 (Sigma aldrich) 
0.2 % Triton-X100 
 
Staining buffer 
10 ml Alkaline phosphatase buffer 











5.8. Western blot analysis 
Western blot is a method used in research to separate and identify proteins. In this technique a 
mixture of proteins is separated based on molecular weight, and thus by type, through gel 
electrophoresis. These results are then transferred to a membrane producing a band for each 
protein. The membrane is then incubated with antibodies specific to the protein of interest 
(60). 
 
Figure 13: Protein molecular standards for Western blot analysis obtained from Invitrogen on the left 
Magicmark and on the right prestained seeblue plus (61). 
 
2 x 25 embryos that were incubated in E3-medium, 1 % EtOH and 2 % EtOH at 24 hpf, 48 
hpf and 72 hpf .The embryos were dechorionised and placed on ice. 
A mastermix was made containing 
 
105 µl NuPAGE® LDS Sample Buffer (4X) 
42 µl NuPAGE® Reducing Agent (10X) 
273 µl Ionized H2O 
420 µl 
 
50 µl of mastermix was pipetted on the embryos and mixed thoroughly 10x by using a pipette 
and then warmed up at 100 ºC for 5 minutes. 
Samples were first sonicated for 2.5 minutes and centrifuged for 2 minutes. 
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NuPAGE® Bis-Tris Gels 4-12 % with NuPAGE® MES SDS with 12 wells was used. 
The gel was removed from the pouch and the comb was smoothly removed. Peeled the tape 
bottom of the cassette. Rinsed the gel-well with 1x SDS running buffer (Nupage). Put 
together the two gels in the Mini-Cell such that the notched “well” side of the cassette faces 
inwards toward the buffer core. Placed the gels on the bottom of the mini-cell and lock into 
place with the gel tension wedge. The inner chamber was filled up with running buffer to 
check for tightness of the seal. SDS running buffer (Nupage) was filled on the outer chamber 
and the samples were loaded into the wells. 5 l of the zebra fish protein samples were 
loaded.1 l Magicmarker (Nupage) and 4 l See Blue Breeze (Nupage) were used as 
molecular weighing protein standards (Figure 13). Electrophoresis was performed at 200V for 
45 minutes. 
A nitrocellulose membrane was cut 7 cm x 7.5 cm and two pieces of filter paper 
About 700 ml Transfer Buffer was used to soak the pads until they were saturated. 
Two soaked blotting pads were placed into the cathode (–) core of the blot module. 
The gel cassette was opened carefully by using a gel knife. 
A piece of pre-soaked filter paper was placed on top of the gel,  
Filter paper saturated with the transfer buffer and all trapped air bubbles were removed by 
gently rolling over the surface using a roller 
The plate was turn over so the gel and filter paper are facing downwards over a gloved hand 
or clean flat surface. 
A Gel Knife to push the foot out of the slot in the plate, and separate the gel from the plate.  
After placing the gel on a flat surface, the foot of the gel was cut off with the Gel knife. The 
pre-soaked transfer membrane was positioned on the gel, ensuring all air bubbles have been 
removed. 
Another pre-soaked filter paper was placed on top of the membrane. Trapped air was 
removed. Placed blotting pads such that the gel is closest to the surface of the cathode core. 
 
 




Added two more pre-soaked blotting pads and placed the anode (+) core on top of the pads. 
The gel/membrane assembly was held securely between the two halves of the blot module 
ensuring complete contact of all components. Positioned the gel/membrane assembly and 
blotting pads in the cathode core of the XCell II™ Blot Module to fit horizontally across the 
bottom of the unit. The blot module was held together firmly and slide into the guide rails on 
the lower Buffer Chamber. The Gel Tension Wedge was placed and locked  (62). 
The gel was blotted for 2 hours on 20V. 
The membrane was transferred to a 50 ml tube with 5 ml of Blocking buffer (Li-COR) was 
left to block overnight at 4 C. 
Replaced with 2 ml of blocking buffer and 2.5 µl of Tween 20, 2.5 µl Anti-pax6 rabbit 
(1:1000) (Millipore). 
Incubated while rolling for 45minutes.Placed 2.5 µl of anti-actin (Sigma) and incubated again 
for 45minutes. 
Membrane was washed 4x5mins with 1xTBST. 
10 ml of 1x TBST was placed and 1 µl of anti-rabbit 680(Li-COR,Odyssey) was added. The 
tube was wrapped with aluminum foil and incubated for another 1 hr. Thereafter washed 4 x 5 
minutes in 1 x TBST. 
Membrane was scanned using ODESSEY LI-COR machine. 
 
 
5.8.1. Western blot assessment using DDT AND SDS 
In one of the researches 2 x SDS and 1M DTT (Dithiothreitol) were used for making the 
samples for Western blot analysis. 160 μl 2x SDS and 40 μl DDT was mixed and 30 μl was 
pipetted on 15 embryos. The same procedure was done as on the previous analysis. 20 µl of 
the protein sample was used on each well. After blotting, and blocking the membrane was 
double stained with primary antibody 5 µl anti-pax6 (sheep) and 2.5 µl anti-actin (rabbit) for 
45 minutes. Washed 4 x 5 min with 1 x TBST. Thereafter incubated in 1µl anti-sheep 






PBS (phosphate-buffered saline) contained 0.1% sodiumazide. 
 
1 x Running buffer 
Diluted form 20 x SDS Running buffer, which contained 
50 mM MES 
50 mM Tris Base 
0,1 % SDS 




29 g trisebase 
144 g glycine 
1 liter methanol 
H2O til 6 liters 
 
1 x TBST 
10 x TBS 
0.1 % Tween 20 
 
TBS 
20 mM Tris, pH 7.5 
500 mM NaCl 
 
2X SDS(Sodium dodecyl sulfate) 
5 ml 1M Tris-HCl, pH 6.8  
10 ml 10 % SDS,  
20 ml 50 % Glycerol  
0.1 g bromphenol blue.   




1M DDT (Dithiothreitol) 
1.54 g Dithiothreitol 
33.3 µl 3M NaOAc, pH 5.2 

















































The main goal was to clone cDNA to zAtoh1a1, zAtoh1a2 and zAtoh1c to make probes that 
could be used as markers in cerebellum, in order to study the effects of alcohol during brain 
development.  The first part of the results describes Cloning experiments while the second 
part contains incubation of embryos in different concentrations of ethanol, In situ 
hybridisation of probes and Western blot analysis. 
 
6.1. Part 1 
Embryos at 24 hpf were used to extract RNA from zebrafish embryos and cDNA was 
synthesized. PCR was then used for amplification of the appropriate target genes from cDNA 
with specific primers from the zAtoh1a1, zAtoh1a2 and zAtoh1c genes. Shh was used as 
positive control. RT-PCR (5.3.1) showed no product of  the Atoh primers (Figure 15A). 
 
Optimization (5.2.2) was done with PCR block gradient, since no conclusive results were 
obtained from RT-PCR. PCR block gradient showed amplification only on Lane 2 at 615 bp 
at 58º C.Rest of the bands showed no amplification (Figure 15B). 
 
A new PCR-reaction with Phusion (5.2.3) was done and PCR products of expected size 
respectively;  zAtoh1a1 at ~553 bp, zAtoh1a2 at ~909 bp and zAtoh1c at ~ 615 bp were 





Figure 15: Optimization of the PCR conditions was required for the successful amplification of the 
zAtoh1a1, zAtoh1a2 and zAtoh1c genomes from cDNA. Lane M, 1kb plus ladder, Figure A, Lane 1 
zAtoh1a1, Lane 2 zatoh1a2, Lane 3 zAtoh1c, Lane 4 zfShh.1 at 768bp (Positive control) Optimization with PCR 
block gradient at 58 ºC (Figure B), from left lane 1-3 zAtoh1a1, Lane 4-6 zatoh1a2, Lane 7-9 zAtoh1c. 










6.1.1. Cloning of PCR® Zero-blunt vector and pbluescript KS +/- 
After PCR amplification of zAtoh1a1, zAtoh1a2 and zAtoh1c cDNA , the PCR products were 
purified and several attempts were done to clone them into the  pZero-blunt vector .Due to the 
difficulty in cloning of PCR-blunt vector pBluescript was used. Linearization of pBluescript 
with EcoRV (5.3.3) gave a bright single band (Figure 16) which was cut out from the gel and 
purified by Qiagen gel purification kit (5.3.3.1). 
PCR products from amplification were used for ligation of pBluescript digested with EcoRV 
and pZero-blunt. Ligation mixtures from pBluescript and pZero-blunt were added to DH5 
competent bacteria cells. Bacteria cell culture was spread on LB plates containing 100 g/ml 
Ampicillin and 50 g/ml Kanamycin. A miniprep light was done (5.3.5) to obtain DNA. DNA 
products were digested with restriction enzymes; EcoRI and Hind III. DNA was set up for gel 
electrophoresis with 0.7 % agarose gel for 40 minutes at 90V. Results of pZero-blunt from 




Figure 16: Linearized p-bluescript with EcoRV 
 
 
Figure 17: Cloning of pZero-blunt showed insert which was digested with EcoRI. From left lane 1-4 
zAtoh1a1 with pZero-blunt, Lane 5-8 zAtoh1a2 with pZero-blunt, Lane 9-12 zAtoh1c with pZero-blunt. Lanes 
with pBluescript digested with EcoRI and Hind III shows no insert at all. Lane 13-16 zAtoh1a1 with pBluescript, 




6.1.2. Sequence for PCR® Zero-blunt vector 
Since cloning of pZero-blunt indicated that there was an insert of PCR products in vector but 
not at the right size plasmid DNA was extracted from pZero-blunt bacteria cultures with 
miniprep (5.3.8) and DNA concentration was measured (Table 4). The mini-preps with the 
appropriate amount of DNA approximately 500 ng/µL, ratio of purity (260/280) nm of ~1.8-
2.0 and secondary measure of nucleic acid purity (260/230) nm of 2.0-2.2 were set up for 
sequence reaction (Table 5). 
The sequencing results showed that it was not the nucleotide sequences of Atoh genes that 
had been cloned. Due to a suspected contamination direct sequence of PCR products was set 
up to find out whether the contamination came from transformed bacteria cell or from the 
PCR products. The results showed that PCR-products contained the right zebrafish zAtoh1a1, 
zAtoh1a2, zAtoh1c genes (Appendix 1). DH5 bacteria culture was streaked directly on a LB-
agar plate containing Kanamycin (50 µg/ml) or Ampicillin (100 µg/ml) but there was growth 





















6.1.3. Cloning of PCR® Zero-blunt vector, PCR2.1 TOPO and pBluescript KS+/- 
A new experiment was done  using other types of vectors as mentioned above (5.3.10) 
No results when obtained from this experiment either, the segments that are seen are larger 
than the expected segments after enzyme digestion. The large segments are determined to be 
the size of vectors (Figure 18); respectively pZero-blunt vector around ~3.5 kb as seen on 
Lane 1-15, however Lane 12 has a segment over 4.4 kb which is the size of vector probably 
with the insert but not digested. Lane 16-23 shows the size of PCR2.1 TOPO 3.9 kb used for 





Figure 18: After digestion of Ecor I and Hind III, cloning of PCR® Zero-blunt vector,PCR2,1 TOPO and  
pBluescript KS +/- in zAtoh1a1, zAtoh1a2, zAtoh1c results show no cloned insert in vector. First lane -1kb 
plus ladder, Lane 1-5 zAtoh1c cloned with pZero-blunt 6-10 zAtoh1a2 with pZero-blunt 11-15  zAtoh1a1 with 
pZero-blunt, Lane 16-20 Atoh1a1 with PCR2,1 TOPO, Lane 21-23 zAtoh1a2 with PCR2.1 TOPO and Lane 24 


















6.1.4. DIG-probe direct from PCR-products 
Since there were problems with the cloning of PCR products containing zAtoh1a1, zAtoh1a2 
and zAtoh1c genes, it was impossible to make plasmids to be used for ISH probe generation. 
However a method using PCR-products as templates for DIG-labeling has been described 
(5.5.4) is possible. To do this, PCR primers with SP6 and T7 binding sites are required. The 
PCR probes successfully used to amplify the Atoh genes were therefore re-ordered with a SP6 
sequence in the 5’ end of the forward primer, and a T7 sequence in the 5’end of the reverse 
primer. After the PCR products were generated and purified, the T7 DNA polymerase was 
used to make DIG-labeled antisense transcripts (= ISH probes). 
 
Labeling of DIG-probe from PCR-products was successful. A strong band of zAtoh1a2 
around 900 bp, and two weaker bands for zAtoh1a2 and zAtoh1c. 
The labeled probes were used for RNA in situ hybridization as described in the next section 
of the thesis. 
 
Figure 19: DIG labeled probe Lane M 1kb-plus ladder, Lane 1 zAtoh1a, Lane 2 zAtoh1a2 and Lane 3 

















6.2. Part II 
 
Zebrafish embryos obtained from mating were incubated in different concentrations of 
ethanol 0.01 %, 0.1 %, 1 %, 2 % and E3-medium for 24 hours, 48 hours and 72 hours. The 
embryos were observed and dead embryos were counted and removed daily. Whitish 
precipitate in the chorion determined that the embryos were dead (5.4.2). Remaining embryos 
were dechorionised. Changes on morphology were registered (10.2) and photographed. A 
Nikon Digital Sight DS-U3 camera was used to photograph the embryos. 
Some embryos were fixed with 4 % PFA and stored at -20ºC for in situ hybridization, while 
the rest were used to make protein extracts for Western blot analysis and stored at -80 ºC. 
 
6.2.1. Zebrafish and mortality  
The percent of death decreases in relation with time of incubation because dead embryos were 
removed daily. 
The number of death varied a lot. There are several factors that influenced mortality such as  
 Quality of the embryos that were used 
 Suffocation of embryos due to lack of oxygen and this could be caused by a large 
number of embryos being incubated in a small petridish. 
Referring to the reasons mentioned above as the cause of mortality for the embryos incubated 
in E3-medium. 
Over all the embryos that were incubated in 2 % ethanol had the highest rate of death from  
24 hpf of incubation up to 72 hpf of incubation (Figure 20). Mortality increased gradually 
over time with longer incubation period. This could be to the fact that incubation of embryos 
in ethanol makes it impossible for embryos to develop thereby causing death. 
 
Embryos that were incubated in 1 % ethanol showed a large number of deaths as well, during 
24 hrs to 48 hrs of incubation. During this period of time the development of the most 
important organs likes the CNS and the brain occurred (7). 
 
Embryos that were incubated in 0.01 % had a large number of deaths during 48 hpf, 
approximately 24 % in comparison with embryos incubated in 24 hpf. While embryos 




Table 8: Total number of death  








24 hpf (n=1380) 24 % 22 % 22 % 22 % 28 % 
48 hpf(n=1380) 18 % 25 % 12 % 17 % 29 % 
72 hpf(n=420) 24 % - - 24 % 25 % 




Figure 20: Number of mortality with time (hours), x-axis shows the mediums used for incubation while 
the y-axis show the total number of death in percent. Embryos incubated in 24 hpf had a raise in lethality 
according to higher concentration of ethanol. 48 hpf had fluctuation in mortality, but the highest number of death 














































6.2.2. Morphological changes in 24 hpf embryos. 
Embryos that were incubated in 1 % ethanol do not show much morphological changes, this 
could be because it is very early in the development stage to conclude if ethanol affects 
embryogenesis since during that period the embryos are still developing or the changes are 
comparatively small and not visible. Embryos that are incubated in 2 % ethanol were 
seriously deformed (Figure 22C) some embryos from 2 % ethanol had yolk sac edema and 
pericardial edema (Table 9). 
Embryos incubated in 1 % ethanol had axial malformation (truncated tail and body axis) 
(Figure 22B). They were inactive in comparison with embryos in E3 medium. Some embryos 
were pale, which could be caused by a delay in development compare to other embryos. 


















E3 19 - - - - - 121 
1 % EtOH 17 13 4 - - 13 123 
2 % EtOH 39 17 24 5 3 3 101 
AM: Axial Malformation, YSE: Yolk Sac Edema, PE: Pericardial Edema, D: deformed, SD: seriously deformed 
N: Total number of embryos 
 
 
Figure 21: Graphical view of different kind of malformations at 24 hpf in control, 1 % and 2 % ethanol. 
Embryos incubated in 2 % ethanol were seriously deformed (SD) and deformed (D) as the graph shows. While 
embryos incubated in 1 % ethanol had a higher rate of axial malformations (AM) and other deformations like 
yolk sac edema (YSE), pericardial edema (PE). 
 
 






















Figure 22:  Overview of embryos incubated for 24 hours in A: E3-medium, B: 1 % Ethanol and C: 2 % 
Ethanol. Embryos incubated in 1 % ethanol (Figure B) shows axial malformation including truncated tail and 
body axis while embryos in 2 % ethanol (Figure C) show severe deformation. 
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6.2.3. Morphological changes in 48 hpf embryos 
Embryos that were incubated in 1 % ethanol showed different malformations including 
pericardial edema, yolk sac edema, and axial malformation (Figure 24B, Table 10). 2 % 
ethanol embryos were not active they appeared to have reduced locomotive senses; they had 
no actual movements and shoaled when touched on the tail. Embryos had axial blistering 
around the tail and their body sizes were reduced, shortened length and had bowed body axis 
(Figure 24 C). They also developed pericardial edema, yolk sac edema and truncation around 
the head area. Most of the embryos in E3-medium and 1 % ethanol showed a sign of delay in 
development, which could be caused by lack of oxygen (a large number of embryos incubated 
in a small dish) or effects of ethanol (Figure 24A, B). 






















E3 18 - - - - - - 122 
1  %  
EtOH 
31 2 5 4 21 20 6 109 
2 % 
EtOH 
41 21 13 44 8 9 103 78 
AM: Axial Malformation, YSE: Yolk Sac Edema, PE: Pericardial Edema D: deformed, SD: seriously deformed 
N: Total number of embryo 
  
Figure 23: Graphical view of different kind of malformations at 48 hpf in control, 1 % and 2 % ethanol. 
Deformations (D) arose frequently in 2 % ethanol embryos. Axial malformation (AM) is dominating in 2 % 
ethanol embryos. While yolk sac edema (YSE) and pericardial edema (PE) occurs currently in embryos 
incubated in 1 % ethanol. 






















Figure 24: Overview of embryos incubated for 48 hours in A: E3-medium, B: 1 % Ethanol and C: 2 % 
Ethanol. Embryos had delay in development (Figure A and B). By a random look embryos in 1 % ethanol 
developed pericardial edema (PE) and yolk sac edema (YSE). Some few embryos survived through incubation in 
2 % ethanol (Figure C) they shows different deformations, including truncation/swelling on head area, PE, YSE, 
shortened body length and axial blistering around the tail. 
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6.2.4. Morphological changes in 72 hpf embryos 
Embryos that were incubated in 1 % ethanol showed the same kind of deformities as embryos 
from 48 hpf (Table 11) Embryos that were incubated in 2 % ethanol had deformations and the 
few that weren’t deformed had other kind of malformation including yolk sac edema (YSE), 
axial malformation (AM), axial blistering (AB) and pericardial edema (PE)(Figure 26C). 
 


































E3 31 1 2 - - - - - 106 
1  % 
EtOH 
26 2 6 3 - 39 30 5 106 
2 % 
EtOH 




11 49 49 49 81 
AM: Axial Malformation, YSE: Yolk Sac Edema, PE: Pericardial Edema, D: deformed, SD: seriously deformed 
N: Total number of embryos 
 
 
Figure 25: Graphical view of different kind of malformation at 72 hpf in control, 1 % and 2 % ethanol. 
Embryos incubated in 2 % ethanol indicated persistent occurrence in variety of malformations including axial 
malformation (AM), yolk sac edema (YSE), pericardial edema (PE). A higher number in the embryos seriously 
deformed (SD) and deformed (D). While 1 % ethanol embryos has diversity in deformity, with severity in 
pericardial edema (PE) and yolk sac edema (YSE). 
 
 
























Figure 26: Overview of embryos incubated for 72 hours in A: E3-medium, B: 1 % Ethanol and C: 2 % 
Ethanol. Embryos incubated in 1 % ethanol developed pericardial edema (PE) and yolk sac edema (YSE) and 
truncated body axis. Some few embryos survived through incubation in 2 % ethanol (Figure C) they shows 
different deformations, including truncation/swelling on head area, PE, YSE, shortened body length and axial 




Embryos were incubated too in 0.01 % and 0.1 % ethanol. There were not any changes 




Figure 27: Closer view of embryos that were incubated in different concentrations of ethanol. A and C: 48 
hpf 1% ethanol, B: 72 hpf 1 % ethanol, D: 48 hpf 2 % ethanol, E: 48 hpf 0.01 % ethanol and F: 48 hpf 0.1 % 
ethanol. Most of the embryos incubated in 0.1 % (Figure F) ethanol appeared to be pale, had less pigmentation. 
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Use of DIG-Labeled probes to visualize structures in the eyes and brain in normal 
embryos and embryos exposed to ethanol. 
DIG-labeled PCR-products zAtoh1a1, zAtoh1a2 and zAtoh1c (6.1.4) were supposed to be 
used for in situ hybridization to visualize structures of the eyes and brains. Cloning was not 
successful and DIG labeled of PCR products (Figure 19) did not give results when used for in 
situ hybridization experiments (results not shown). 
Therefore Pax6.1 and Pax2.1 DIG labeled probes were used as replacement. 
 
Anti-sense probes were DIG-labeled by linearization of the plasmid and application of T7-
DNA polymerase for transcription of antisense strand. Pax6.1 and Pax2.1 containing plasmids 
were digested with EcoRI (Figure 28A) for 3-5 hours at 37 ºC (5.5.1), thereafter DIG labeled 
to generate the Pax6.1 and Pax2.1 anti-sense probes (Figure 28B). 
The bands obtained shows low intensity, which reflects that the amount of probes was low 
(Figure 28B). This indicates that larger amount of probe is needed per experiment during in 
situ hybridization (ISH). Spot test assay was used to estimate the concentration of probes to 
be used (Figure 29). 
 
 
Figure 28: Lane M 1kb plus ladder, Figure A shows linearization of plasmid after EcoRI digestion Lane 1 











6.3. Spot test assay 
Spot test assay was used to estimate the concentration of probes to be used for in situ 
hybridisation experiments (Figure 29) 
 
Figure 29: Spot test OF DIG-labeled probes, Upper row: Control Probe, Middle row: Pax6.1, Lower row: 
Pax2.1. Based on comparison with the control Dilutions the amount of probe was estimated to be 100 ng/ µl 
(Pax2.1 and Pax6.1). From the membrane antibody/alkaline phosphatase was spotted at 100 pg/ µl 
100 pg/ µl *1000= 100 ng/ µl. As thumb of rules use 0.5 -1 µg probe for in situ hybridisation, thereby 500 ng is 



























6.4. Overview of Pax6.1 and Pax2.1 Probe after RNA-in situ hybdridisation 
Anti-DIG antibody conjugated to the enzyme alkaline phosphatase was used to bind the DIG-
labeled probes hybridized to the RNA transcribed from the target genes.  
 
Pax6.1 and Pax2.1 (Figure 30) ISH probes were used as positive controls. In situ RNA 
hybridisation was used to visualize the gene expression pattern in the embryos incubated with 
ethanol. Pax2.1 is localized at the midbrain-hindbrain border and is usually recognized by a 
stripe (furrow separating the midbrain and the hindbrain) and around the optic stalk at early 
stages of embryonic development (48) (Figure 30A). While Pax6 is expressed in at uniform 
manner in whole eye at 24 hours of development excluding the anterior part of the optic stalk 
(63), including the retina, lens and cornea (Figure 30B). In addition it is expressed in the 
hindbrain. Pax6.1 and Pax2.1 labeled probes were pooled together to be able to stain the eye 
and the stripe at the midbrain-hindbrain border (MHB) and the hindbrain simultaneously. 
 
 
Figure 30: Pax6.1 and Pax2.1 were used as controls to visualize regions of the brain and eyes in 24 hpf 
embryos. Figure A, 24 hpf with Pax2.1 staining, shows stripe around the midbrain and hindbrain and weak 
staining around the eye (Optic stalk), Figure B with 24 hpf, Pax6.1 show intense staining around the eye and the 












6.4.1. Zebrafish embryos (24 hpf) with Pax6.1 and Pax2.1 Probe 
 
Embryo incubated in 1 % and 2 % ethanol doesn’t show much difference in comparison to     
the embryo from E3-medium (Figure 31A). Since it was difficult to observe the morphology 
changes staining of the embryos was an option used in order to observe the changes and 
measure the size of the brain structure. No clear visible reduction of eye size or reduction in 
staining. For embryos incubated in 2 % ethanol, the staining clearly indicated abnormal 




Figure 31: Lateral view of 24 hpf embryos with whole mounted probes against Pax6.1 and Pax2.1 were 
used to visualize regions of the brain and eyes in 24 hpf embryos incubated with 1 % and 2 % ethanol; A: E3-
Medium, B: 1 % Ethanol, C: 2 % Ethanol. 
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6.4.2. Zebrafish embryos (48 hpf) with Pax6.1 and Pax2.1 Probe 
 
Embryo incubated in 2 % ethanol (Figure 32C) had the weakest staining and this shows us 
that there is less Pax6.1 gene expressed in the eyes when embryos are exposed to this 
concentration of ethanol. Pax6 is said to be the master gene for eye development (43) and 
reduction of it can cause suppression in retina neurogenesis and reduced lens size. Pax2.1 is 
visible in a closer look at 2 % ethanol but weaker too.  Control embryo (Figure 32A) shows 
strong intensity of staining around the eye, when compared to embryo incubated in 1 % 





Figure 32: Dorsal views of 48 hpf whole-mounted embryos with probes against Pax6.1 and Pax2.1 A: E3-
Medium, B: 1 % Ethanol, C: 2 % Ethanol, Stronger staining in Figure A and B in comparison with Figure C, 




6.4.3. Zebrafish embryos (72 hpf) with Pax6.1 and Pax2.1 Probe 
 
Embryo incubated in E3-medium (Figure 33A) shows no changes in the retina and the lens in 
comparison to the embryo incubated in 1 % ethanol (Figure 33B) and 2 % ethanol which 
showed weaker Pax6.1 expressions with higher concentration of ethanol that could influence 
development of the retina and the lens. It wasn’t able to see the Pax2.1 in this stage of 
development 72 hpf because the embryos brain is fully developed and the tectal ventricle 
enlarges, thus the tissue between the furrow separating the midbrain and the hindbrain gets 










Figure 33: Dorsal views of whole-mounted embryos 72 hpf labeled with RNA probes against Pax6.1 and 
Pax2.1 (A-C) A: Control, B: 1 % Ethanol, C: 2 % Ethanol. Alcohol induced reduction of the retina and lens size. 
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6.5. Pax6.1 and Pax2.1 probe measurements 
Since there were no obvious differences in the in situ staining pattern in embryos incubated in 
the lower concentrations of ethanol compared to the control, measurements were done to see 
if ethanol influences the eye size. The junction between the midbrain and hindbrain will 
become the cerebellum. We were interested to see if there were disturbances in the 
development of this area of the brain at this early stage. To do this the staining of Pax2.1 in 
the stripe marking the midbrain-hindbrain border (MHB), and the staining of Pax6.1 
expression in the hindbrain was used. The gap between these staining was measured to see if 
there were changes in the presence of ethanol. Measurements on the eye were done also to see 
if ethanol influences the eye development. 
  
 
Figure 34: An overview of how the lateral and dorsal measurements were done. Measurements were done 
on the computer using Nikon Digital Sight DS-U3 camera and a program called NSCEI. 
 
Evaluation of data 
Data were evaluated as the mean ± standard error of mean (S.E.M) and analyzed for statistical 
significance by using p-value was calculated by using Excel (Student t-test, two sided, 
assuming unequal variance). 
According to my calculation of t-test, there was a lot of variation on the results. I conclude 
that there is a significance difference whether the measurements of the junction between the 
brain was done lateral or dorsal. However the lateral and dorsal measurements of 24hpf shows 
inconsistency in the p-value where E3-medium and 1 % ethanol incubated embryos had a 
p>0.05 and 0.1 % ethanol had p<0.05. Measurements for the 48 hpf embryos show a 
significant difference p<0.05, which could be caused by imprecise positioning of embryos 
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while taking measurements; this could be a factor influencing variety in the measurements. I 
nevertheless decided to use both the lateral and dorsal measurements for further discussion. 
 
 
6.5.1. Measurements of the eye and the distance between midbrain/hindbrain in 24hpf 
embryos 
A t-test was done to compare if there was significance difference in the embryos incubated in 
E3-medium with those in 0.1 % ethanol and 1 % ethanol. 
Lateral and dorsal measurements of the previously described brain area in embryos incubated 
in 24 hpf 1 % showed a p-value > 0.05 while the measurements of embryos incubated in 24 
hpf 0.1 % ethanol shows significance difference with a p<0.05. This shows us that ethanol 
influences the size of MHB in early embryogenesis, by reducing the gap between the 
midbrain and the hindbrain (Figure 35) 
The eye size in 24 hpf 1% ethanol and 0.1% ethanol, shows a p-value > 0.05, which 
paraphrases that ethanol, does not reduce the eye size in 24 hpf hence no significance 
difference. To conclude, the only significant difference observed with these measurements 
were the lateral/dorsal measurement distance of the midbrain /hindbrain junction for embryos 
at 24 hpf incubated with 0.1 % ethanol compared to embryos incubated with E3. 
 
Table 12: Average measurements of the eye and the distance between the midbrain/hindbrain for 24 hpf 
 Mean eye size 
(m)  ±  STD 
Mean lateral 
Midbrain/hindbrai
n distance (m)     
± STD 
Mean Dorsal 
Midbrain/Hindbrain   
distance ( m) 
±  STD 
 E3medium 13.3 ± 2.0(n=4) 5.1 ± 0.4 5.2 ± 0.5 
0.1% EtOH 12.8 ± 1.0(n=4) 4.1 ± 0.4 5.9 ± 0.3 
1% EtOH 12.5 ± 2.3(n=5) 4.5 ± 1.2 4.5 ± 0.4 
 
STD: Estimated standard derivation 
n:reflects the number of embryos that were measured for visualization of the Pax6.1 around 
the eye and Pax2.1 around the junction of the  midbrain/hindbrain. 
p-value given < 0.05 as significant, p< .001 given as highly significant 






Figure 35: Measurement of the distance between midbrain/hindbrain and eye size in 24 hpf embryos 
incubated in E3-medium, 0.1 % ethanol and 1 % ethanol. Eye size measurements of 1 % ethanol and 0.1 % 








































6.5.2. Measurements of the eye and the distance between midbrain/hindbrain in 48 hpf 
embryos 
Measurement of the lateral and dorsal (MHB) in embryos incubated in 48 hpf 0.1 % and 1% 
shows no significance difference with a p-value > 0.05. Although the overview of the graph 
(Figure 36) shows that there is a reduction on the size of MHB especially in the embryos 
incubated in 1 % and a slight reduction in the eye size. 
In general graphical interpretation measurements of the eye size shows no significance 
difference. The measurements of the eye size on embryos incubated in 0.1 % ethanol and 1 % 
ethanol for 48 hpf has a p>0.05. 
 
Table 13: Average measurements of the eye and distance between the midbrain/hindbrain for 48 hpf 
 Mean eye size 








(m)  ±  STD 
E3medium 9.3 ± 1.6 (n=10) 3.8 ± 0.5  4.4  ± 0.7 
0,1 % EtOH 9.3 ± 1.6 (n=10) 3.7 ± 0.4 4.6 ± 1.1 
1 % EtOH 8.93 ± 1.6(n=13) 3.5 ± 0.7 4.5 ± 1.0 
 
STD: Estimated standard deviation 
n:reflects the number of embryos that were measured for visualization of the Pax6.1 around 
the eye and Pax2.1 around the junction of the  midbrain/hindbrain. 
p-value given < 0.05 significant,p<0,01 given as highly significant 














Figure 36: Measurement of the distance between the midbrain/hindbrain and eye size in 48 hpf embryos 
incubated in E3-medium, 0.1 % ethanol and 1 % ethanol. Measurements on the eye size show no significance 









































6.6. Pax6 in Western blot analysis 
We wanted to study if Pax6 was influenced by ethanol. A reduction of Pax6 proteins was 
expected in ethanol-incubated embryos since it has been published that alcohol reduces Pax6 
expression and with higher concentration of alcohol Pax6 proteins are almost suppressed (64) 
Protein extracts were prepared from ethanol incubated embryos and control embryos. Protein 
samples of 15 embryos were prepared for analysis (5.8) Extracts from 10 embryos were 
loaded on the gel where the proteins were separated with gel electrophoresis. A nitrocellulose 
membrane was used to absorb the separated proteins. Thereafter primary and secondary 
antibodies were used to mark the protein of interest. 
Pax6 is identified around 48kDa and actin around 42kDa (Figure 37) .The membrane for 
Western blot analysis shows a weaker band at 1 % and almost diminished band at 2 % 
indicating that there is a reduction in the amount of Pax6 protein in the embryos that were 
incubated in 2 % alcohol. The results from 48 hpf and 72 hpf could not be used because all of 
the bands on the blot were very blurry. This could be caused by viscosity of the zebrafish 




Figure 37: Western blot analysis assessing Pax6 in zebrafish embryos incubated in E3-medium,1 % 
ethanol and 2 % ethanol for 24 hpf. A weak band with low intensity on 24 hpf 2 % ethanol which shows a 








Several Western blot assessments were done was redone using NUPAGE LDS buffer and 
Reducing agent (Figure 38) by changing the amount of protein loaded . An amount of protein 
equivalent to 2.5 embryos were loaded per well. A clear band of Pax6 is identified but no 
changes from the samples incubated in ethanol or control samples (E3-medium). A thinner 
band on 24 hpf E3-medium, 1 % ethanol and 2 % ethanol which could be due to the little 




Figure 38: Western blot analysis assessing Pax6 in zebrafish embryos incubated in E3-medium, 1 % 
ethanol and 2 % ethanol for 24 hpf, 48 hpf and 72 hpf. Weak intensity on the 24 hpf with antibody against 
Pax6 and actin Pax6 was used as positive control at the last band. Band ´from 48 hpf and 72 hpf seem to have 


























7.1. Summary of results: 
The objective of this thesis was to study how ethanol affects zebrafish embryo development. 
Tools were generated to study specific parts of the brain, zAtoh1a1, zAtoh1a2 and zAtohlc 
genes which are expressed in the cerebellum were isolated from zebrafish cDNA and cloned 
to be used for in situ hybridization. Cloning was not successful and DIG labeling of PCR 
products did not give results. Therefore Pax6.1 and Pax2.1 gene expressions were further 
used to study ethanol effects on zebrafish embryos. 
 
Zebrafish embryos were incubated with different concentrations of ethanol to look for 
changes in overall morphology and survival. Studies on the molecular level, including in situ 
hybridizations and Western blot of protein extracts are also to be included.  
 
Incubation of embryos in different concentrations of alcohol in chronological order (24 hours, 
48 hours and 72 hours) lead to morphological changes including pericardial edema, yolk sac 
edema, axial malformations, axial blistering, shortened body length and whole embryo 
deformations. 
 
Ethanol influenced Pax6.1 and Pax2.1 gene expression depending of the stage of embryo 
development and concentration used. Cleary Pax6.1 expressions are reduced during 48-72 hpf 
embryos and this was determined by decreased intensity of staining of in situ hybridization 
probes in the retina and lens. Although the measurements that were done on the eye size 
confirmed no reduction of the eye size. 
 
Measurements of the eye size for embryos harvested in 1 % ethanol during 24 hours does not 
appear to be influenced by ethanol. But the measured region just posterior to the midbrain 
hindbrain boundary (MHB) is reduced in size during the first 24 hours of embryogenesis. 
Embryos incubated for 48 hours in ethanol shows no reduction in the junction between the 
midbrain and the hindbrain, while the eye size is slightly reduced. 
 
Western blots (WB) assessment were done to study if Pax6 was influenced by ethanol. A 
reduction of Pax6 proteins was expected in ethanol incubated embryos since it has been 
manifested that alcohol reduces Pax6 expression and with higher concentration of alcohol 
84 
 
Pax6 proteins are suppressed hence induction of ocular abnormalities (64) Our first WB 
analysis clearly shows (Figure 37) that the amount of Pax6 proteins is decreased in embryos 
incubated in ethanol however technical difficulties in the experiments led to conflicting 
results. Due to a number of reasons discussed (7.5) which made it difficult to conclude if 
Pax6 proteins are affected by ethanol. 
 
 General discussion   
Children with Fetal Alcohol syndrome (FAS) show a variety of ophthalmic disorders. One 
common phenotype seen in humans exposed to ethanol in utero is microphthalmia. 
Microphthalmia is seen in 90 % of children with FAS. Ethanol induced microphthalmia can 
occur as a consequence of a number of potential mechanisms including general development 
delay, increased cell death, reduced cell proliferation and reduced cell differentiation with the 
developing eye (65). During 24 to 48 hours after fertilization the retinal neuroiepithelium 
undergoes rapid proliferation and differentiation to form a laminated structured composed of 
different retinal cell types (21, 66, 67). 
 
Several studies have revealed on how ethanol affects the development of the brain, however 
no study has been published yet to show if ethanol influences the development of the stripe 
with where Pax2.1 is expressed on the junction of the midbrain and the hindbrain. 
 
Various mechanisms are declared as possible targets that can lead to ethanol mediated toxicity 
(1.6). Predominantly there is an association on mechanisms of signal pathways, which might 
lead to FAS. Shh seems to be implicated as the midline of these manifestations. It is 
highlighted that ethanol affects the GABAergic and GLUTAergic neurons in the CNS by 
disrupting sonic hedgehog (Shh), fibroblast Growth Factors (fgf 19), fgf3, fgf8, and Atohnal 
expressions. Agrin is required for proper Shh signaling in the eye development and for the 
generation of serotonergic/dopaminergic neurons. 
 
In Fetal Alcohol Syndrome, delay closure of the neural tube is noted. There is a study that 
shows that alcohol affects the fetal neural stem cells that produce most of the neurons of the 
adult brain (68) and that it affects  serotonergic hydoxytryptamine pathway (HT), by reducing 
the number and density of 5HT neurons in the developing embryo (69). 
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Factors emanating the midline and MHB, mediate serotonergic and dopaminergic neuron 
development. Signal pathways responsible for this are Shh eminating from the midline, Fgf8 
emanating from the MHB and fgf4 from the underlying tissues (70). 
 
Fgf8 depends on the signaling from Shh in the brain. This growth factor is defined to be the 
organizers of Pax2.1 in the MHB (37) Since ethanol impairs Shh signaling, this could affect 
Fgf8 and hence Pax2.1 in MHB, which might cause reduction in the gap between the stripe 
which separates the midbrain and the hindbrain (4). 
 
 
Shh signaling seems to be the main target for both Pax2.1 and Pax6.1 expressions in the eye 
and cerebellum. Overexpression of Shh leads to depletion of the cells restraining Pax6 and 
elevate the number of cells containing Pax2 in the eyes (22). 
 
It is known that overexpression of Shh in zebrafish, ventralises the optic cup, giving an 
expanded Pax2.1 domain at the expense of Pax6 domain and subsequently an expanded optic 
stalk and reduced retina size (microphthalmia) (21). A mechanism has been found in zebrafish 
where Shh is required to promote the wave front of retinal ganglion cell (RCG) differentiation 
and induce its own expression. Both Shh and Atonal (Ath5) are first expressed in the 
differentiating RCGs close to the optic stalk and subsequently this expression spreads (71). 
 
Ethanol suppresses Pax6.1 and hence induces microphthalmia. Basing on that fact, it gives us 
as assumption that ethanol induces the expression of Shh hence repression of Pax6 through 
Pax2.1 in the eyes (22, 46), However several studies display that  craniofacial abnormalities 
are induced by loss of Shh, hence Fetal alcohol syndrome (72, 73). 
 
 
7.2. Mating and dechorioniation: 
 The zebrafish laid a lot of eggs. Embryos obtained through mating were incubated in ethanol 
and E3-medium. After incubation for 24 hours, 48 hours and 72 hours, the embryos were 




7.3. Cloning  
Cloning of DNA from the zebrafish Atoh genes did not succeed as planned. 
Several sources of error could be determined as causes including:- a wrong enzyme used 
during PCR synthesis, where the DyNAzyme DNA polymerase was used instead of the  
Phusion. This made it difficult to clone PCR products in the pZero-blunt vector. Since a 
linearized blunt vector was used which has complimentary blunt ends, using   DyNAzyme 
would make it incompatible since the enzyme generate PCR-productss with an 
overhang/sticky ends .The Phusion DNA polymerase produce blunt-end PCR products and  
was supposed to be the preferable enzyme. The DyNAzyme DNA polymerase is used for 
transformation of vector like PCR TOPO 2.1, which requires a T/A overhang. 
Furthermore it turned out that the competent bacteria cells used for transformation of cloned 
PCR products were contaminated. This caused a lot of “false positives” to be analyzed, and 
these were shown to be plasmid containing inserts that were not the zAtoh PCR products. 
Since direct sequencing of the PCR products verified that they were correct, the observed 
contamination had to come from another step in the cloning procedure. The competent DH5 
bacteria cells were tested by streaking them direct on LB-medium agar plates containing 
antibiotics, but there were growth on both plates which shows that the cells were 
contaminated with plasmids providing antibiotic resistance. 
Another suspicion came up that there might be a contamination on the Cloning kit used; 
thereby a new cloning kit was used; yet the same results were obtained. 
 
 
7.4. Whole-mount in situ hybridization (ISH) 
To study expression of different genes on the ethanol-incubated embryos several experiments 
were done using the probes that were DIG labeled (zAtoh1a1, zAtoh1a2, zAtoh1c, Pax6.1 and 
Pax2.1). Staining the embryos with DIG labeled (zAtoh1a1, zAtoh1a2 and zAtoh1c probes) 
was not successful and this could be due to several reasons. 
Maintenance of the right temperature during hybridization and washing after hybridization 
could be one source of error. During hybridization the temperature of the denatured probes 
was supposed to be exact as the hybridization buffer that the embryos were incubated in or the 
probe would not be effective to label/mark the desired areas of the brain/eyes. The 
temperature of the buffer solutions used during the washing process was supposed to be 
approximately the same as the temperature of the discarded buffers. Since the whole process 
87 
 
requires precision while pipetting the buffers back and forth temperature management could 
be an issue. 
 
Another reason could be under-digestion with Proteinase K which was used to permeabilize 
the embryos, so as to remove proteins that surround nucleic acids (74). Under digestion will 
not allow the probe to penetrate in the embryos (75), while over digestion will make the 
embryo disintegrate and alter the morphology (76). Embryos DIG-marked with zAtoh1a1, 
zAtoh1a2 and zAtoh1c could possibly have been under-digested with Proteinase K, or 
possibly the low concentration of the probes (6.1.4) hence unable to mark the desired areas. 
Over-fixation of the embryos is another factor, this process can make the embryos very 
fragile. Tissue fixation is used to maintain the tissue architecture as well as to ensure the 
retention of the target RNA or DNA and influence probe penetration to the target genome 
(74).Over-fixation can make it difficult to mark the probes and diminish the quality of ISH 
(76). 
 
Although there was an addition of Tween 20 in almost all the buffers, fixed embryos could 
stick together into clumps, which could avoid penetration of probes, but yet embryos that 
were not stuck together were available and staining could be detected. 
To be able to distinguish between problems due to bad probe quality and problems caused by 
failure somewhere along the in situ hybridization protocol, positive and negative controls 
were always included. Embryos where no probes were added (but secondary antibody and 
staining was performed anyway) used as negative control. A probe already used before, where 
the quality had been approved were used as a positive control. Several experiments were done 
on treated and untreated embryos to get familiar with the basal staining and inherent 
variability of the staining  (76). 
In order to get a strong intensity of staining the embryos were incubated at 4ºC overnight with 









7.5. Western blot analysis 
Furthermore to confirm if Pax6 is influenced by ethanol, Western blot analysis was done on 
embryos incubated in E3-medium, 1 % and 2 % ethanol for 24 hours, 48 hours and 72 hours. 
Protein samples of 15 embryos were prepared on the first analysis. Protein samples of 10 
embryos was used per well and the results from 24 hpf seemed to be as expected. A reduction, 
hence suppression of Pax6 proteins was expected in the embryos incubated in high 
concentration of ethanol (64). But from the second analysis blue fuzzy smear bands appeared 
on the background of the membranes from most of the experiments and the protein bands on 
the membrane appeared blurry. This was observed several times. 
Different attempts were done to make this protocol successful. A number of causes were 
suspected including, problems with the LDS loading buffer .A possible explanation could be 
unstable buffer temperature. The LDS buffer used was stored in the refrigerator while it is 
supposed to be stored in normal room temperature. LDS buffer contains glycerol, which 
becomes viscous and sticky when stored at lower temperatures, which might change the 
concentration of the preferred buffer solution. Several experiments were done by maintaining 
the correct standards of the protocol but yet the fuzzy smear bands reappeared. 
Incorrect use of buffer system instead of NUPAGE Tris-Acetate SDS Running buffer and 
NUPAGE LDS sample buffer on the NUPAGE Tris-Acetate Gels could result on fuzzy 
smear bands, but that would not be a source of error in this case, since the right type of 
buffers were used.  
 
Furthermore another assumption was that the fuzzy smear bands could be caused by overload 
of protein per well.  
Accordingly, adjustment of the tissue samples were done from 20 l (10 crushed embryos) to 
5 l (2.5 crushed embryos) to assure that there wasn’t an overload of proteins in each well yet 
the results were the same. 
Contamination with membranes or DNA complexes in the sample could be a considerable 
source of error, which could cause streaking of proteins but due to lack of time this (62). 
 
This procedure gives us information of overall reduction of Pax6 expressions but it does not 
explain in which area the reduction occurs. It can used as an addition method incase several 
protocols are experimented to help make confirmation of the results. 
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7.6. Future perspectives 
The effects of ethanol during embryogenesis are clearly known but methods on how to reduce 
and avoid these effects of Fetal alcohol syndrome are still unknown. With further studies on 
how ethanol affects different transcription factors on the molecular level it will make it 
possible to find the target genes and provide knowledge on how effects of ethanol can be 
countered. 
Injection of Shh m-RNA simultaneously with alcohol exposure of embryos can result into 
reduction of alcohol induced toxicity like cyclopia, body length and other body malformations 
(33, 73). Since Ethanol is known to repress Shh. Shh/fgf3 Morpholino 
oligonucleotides/transient genes could be injected in embryos before incubating in ethanol 
and thereafter the embryos can be marked with zAtoh1a/Pax6.1 and zAtoh1c/Pax2.1 so as to 
study if still ethanol affects these transcription factors or the regions of the brain where these 




















High concentration of ethanol (2 %) lead to gross deformations, while lower concentrations 
0.1 % and 1 % lead to ethanol mediated toxicity including microphthalmia and body 
malformations. 
Ethanol (2 %) harvested embryos for 72 hours induced microphthalmia hence reduced retina 
and lens size. Measurements on the eye size conclude that Pax6.1 expression is not 
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NCBI-blast confirmed that the nucleotide sequence contained Atoh1a 
Danio rerio atonal homolog 1a (atoh1a), mRNA 
Sequence ID: ref|NM_131091.1| 
Length: 906Number of Matches: 1 
 
Query  16  AGTACCCACCAGCCTTGGCACTCATGGCCAGCAGTGACCCACGCGCCTGGCTGGCTCCCG 75                
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  173 AGTACCCACCAGCCTTGGCACTCATGGCCAGCAGTGACCCACGCGCCTGGCTGGCTCCCG 232  
Query  76  TGCAGGCTGGCACCTGCGCGGCACACGCCGAATACCTGCTGCACTCGCCCGGCTCGAGCG 135              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  233 TGCAGGCTGGCACCTGCGCGGCACACGCCGAATACCTGCTGCACTCGCCCGGCTCGAGCG 292  
Query  136 CGGAAGGCGTGTCCTCTGCCTCCAACTTCAGGAAGAGCAGCAAGAGTCCTGTCAAAGTAC 195               
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  293 CGGAAGGCGTGTCCTCTGCCTCCAACTTCAGGAAGAGCAGCAAGAGTCCTGTCAAAGTAC 352  
Query  196 GCGAGCTCTGCCGGCTTAAAGGAGCTGTGGGGGCAGATGAGGGCAGACAGCGGGCCCCAT 255              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  353 GCGAGCTCTGCCGGCTTAAAGGAGCTGTGGGGGCAGATGAGGGCAGACAGCGGGCCCCAT 412  
Query  256 CCAGCAAATCCACCAACGTCGTGCAGAAACAGAGGCGAATGGCTGCCAATGCCCGGGAGA 315              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  413 CCAGCAAATCCACCAACGTCGTGCAGAAACAGAGGCGAATGGCTGCCAATGCCCGGGAGA 472  
Query  316 GGCGAAGAATGCACGGATTGAACCACGCGTTCGACGAGCTGCGCAGTGTCATCCCAGCCT 375              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  473 GGCGAAGAATGCACGGATTGAACCACGCGTTCGACGAGCTGCGCAGTGTCATCCCAGCCT 532  
Query  376 TTGACAACGACAAGAAACTCTCCAAGTACGAAACCCTGCAGATGGCCCAGATCTACATCA 435              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  533 TTGACAACGACAAGAAACTCTCCAAGTACGAAACCCTGCAGATGGCCCAGATCTACATCA 592  
Query  436 ACGCCCTGTCCGACTTACTACAGGGCCCCGGTGCTAAAGCCGACCCGCCAAACTGCGACC 495              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  593 ACGCCCTGTCCGACTTACTACAGGGCCCCGGTGCTAAAGCCGACCCGCCAAACTGCGACC 652  
Query  496 TGCTGCATGCCAAC  509                 
           ||||||||||||||  
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NCBI-blast confirmed that the nucleotide sequence contained Atoh1a2 
Danio rerio atonal homolog 1a (atoh1a), mRNA 
Sequence ID: ref|NM_131091.1| 
Length: 906 Number of Matches: 1 
 
Query  16  AGTACCCACCAGCCTTGGCACTCATGGCCAGCAGTGACCCACGCGCCTGGCTGGCTCCCG 75                                             
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct 173  AGTACCCACCAGCCTTGGCACTCATGGCCAGCAGTGACCCACGCGCCTGGCTGGCTCCCG 232  
Query  76  TGCAGGCTGGCACCTGCGCGGCACACGCCGAATACCTGCTGCACTCGCCCGGCTCGAGCG 135              
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  233 TGCAGGCTGGCACCTGCGCGGCACACGCCGAATACCTGCTGCACTCGCCCGGCTCGAGCG 292  
Query  136 CGGAAGGCGTGTCCTCTGCCTCCAACTTCAGGAAGAGCAGCAAGAGTCCTGTCAAAGTAC 195              
           ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  293 CGGAAGGCGTGTCCTCTGCCTCCAACTTCAGGAAGAGCAGCAAGAGTCCTGTCAAAGTAC 352  
Query  196 GCGAGCTCTGCCGGCTTAAAGGAGCTGTGGGGGCAGATGAGGGCAGACAGCGGGCCCCAT 255              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  353 GCGAGCTCTGCCGGCTTAAAGGAGCTGTGGGGGCAGATGAGGGCAGACAGCGGGCCCCAT 412  
Query  256 CCAGCAAATCCACCAACGTCGTGCAGAAACAGAGGCGAATGGCTGCCAATGCCCGGGAGA 315              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  413 CCAGCAAATCCACCAACGTCGTGCAGAAACAGAGGCGAATGGCTGCCAATGCCCGGGAGA 472  
Query  316 GGCGAAGAATGCACGGATTGAACCACGCGTTCGACGAGCTGCGCAGTGTCATCCCAGCCT 375              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  473 GGCGAAGAATGCACGGATTGAACCACGCGTTCGACGAGCTGCGCAGTGTCATCCCAGCCT 532  
Query  376 TTGACAACGACAAGAAACTCTCCAAGTACGAAACCCTGCAGATGGCCCAGATCTACATCA 435              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  533 TTGACAACGACAAGAAACTCTCCAAGTACGAAACCCTGCAGATGGCCCAGATCTACATCA 592  
Query  436 ACGCCCTGTCCGACTTACTACAGGGCCCCGGTGCTAAAGCCGACCCGCCAAACTGCGACC 495              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  593 ACGCCCTGTCCGACTTACTACAGGGCCCCGGTGCTAAAGCCGACCCGCCAAACTGCGACC 652  
Query  496  TGCTGCATGCCAAC  509              
            ||||||||||||||  
Sbjct  653  TGCTGCATGCCAAC  666  
 
  
Alignment statistics for match #1 
Score Expect Identities Gaps Strand 
















NCBI-blast confirmed that the nucleotide sequence contained Atoh1c 
Danio rerio atoh1c mRNA, partial cds 
Sequence ID: dbj|AB530457.1| 
Length: 779Number of Matches: 1 
 
 
Query  28  CTCAGAGCAGTGTCCCAAAGCCCCAATGGGCTGGAGAGAGGAGCASCTGCAGGACAGGGC 87               
           ||||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||  
Sbjct  82  CTCAGAGCAGTGTCCCAAAGCCCCAATGGGCTGGAGAGAGGAGCAGCTGCAGGACAGGGC 141  
Query  88  GAGCTGTGACCCCTGCGCACTCGTCCAGCTCCGGCTCACTGGCCTTTCATATYCCAGTGA 147              
           |||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||| 
Sbjct  142 GAGCTGTGACCCCTGCGCACTCGTCCAGCTCCGGCTCACTGGCCTTTCATATCCCAGTGA 201  
Query  148 AGAGCAGAGCTCTATCGCCCGAGCCCGGAGGCGTCGCAGACTAGCCGCTAACGCCCGAGA 207              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  202 AGAGCAGAGCTCTATCGCCCGAGCCCGGAGGCGTCGCAGACTAGCCGCTAACGCCCGAGA 261  
Query  208 GAGGAGGAGGATGCTGGGCTTGAAYGTGGCYTTCGACCGCCTGAGGAGTGTTATTCCTAA 267                
           |||||||||||||||||||||||| ||||| ||||||||||||||||||||||||||||| 
Sbjct  262 GAGGAGGAGGATGCTGGGCTTGAACGTGGCTTTCGACCGCCTGAGGAGTGTTATTCCTAA 321  
Query  268 TGTGGAGAGTGACAGGAAGCTGTCCAAGTCTGAGACGCTTCAGATGGCACAGATCTACAT 327              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  322 TGTGGAGAGTGACAGGAAGCTGTCCAAGTCTGAGACGCTTCAGATGGCACAGATCTACAT 381  
Query  328 CAGCACCCTGAGTGAGCTACTGGAGGACAAAGAKTGTGACCCARAAAYCCCATACCCRAC 387              
           ||||||||||||||||||||||||||||||||| ||||||||| ||| ||||||||| || 
Sbjct  382 CAGCACCCTGAGTGAGCTACTGGAGGACAAAGATTGTGACCCAGAAATCCCATACCCGAC 441  
Query  388 TTTGACCATGCAGGATCAGGACATCRCGAAGGGGTTGCCTATGACCGAAGAGACCAAAAC 447              
           ||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||| 
Sbjct  442 TTTGACCATGCAGGATCAGGACATCGCGAAGGGGTTGCCTATGACCGAAGAGACCAAAAC 501  
Query  448 AGAACTCAAGAACAATCCCACCTGTAGGATAAGATCATATAATGGGAATTTTGGGTGCCT 507              
           |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  502 AGAACTCAAGAACAATCCCACCTGTAGGATAAGATCATATAATGGGAATTTTGGGTGCCT 561  
Query  508 AACTTGSAGTGACCRCAAAACAGCTGAACTCTTAGTGGACTCTCACTGTCTGGAAAGGAA 567              
           |||||| ||||||| ||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  562 AACTTGCAGTGACCACAAAACAGCTGAACTCTTAGTGGACTCTCACTGTCTGGAAAGGAA 621  
Query  568 CAATGGTGTAAAATAG  583                                                              
           ||||||||||||||||  
Sbjct  622 CAATGGTGTAAAATAG  637 
 
Alignment statistics for match #1 
Score Expect Identities Gaps Strand 
987 bits(534) 0.0 545/556(98%) 0/556(0%) Plus/Plus 
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10.2. Appendix 2 
10.2.1. Overview of experiments done with incubations with different concentrations of  
alcohol 
  
Table 14: Experiment 1, 3 and 6 for 24 hpf 
  
 N=Mortality 












































































































after 24 hrs 
 
N=Mortality 












































































































































Table 16: Experiments for 72 hpf 
  
N=Mortality 
after 24 hrs 
 
N=Mortality 
after 48 hrs 
 
N=Mortality 



















































































































Table 17: Experiment 2 with 24 hpf 
   







































Table 18: Experiment for 48 hpf 














































































































Experiment 4 og 5 

































































































































Table 20: Experiments for 48 hpf 



























































































AM: Axial Malformation, YSE: Yolk Sac Edema, PE: Pericardial Edema, D: deformed, SD: seriously deformed 
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10.3. Appendix 3 
10.3.1. Overview of eye measurements and midbrain-hindbrain junction 
 
P-value is for the lateral and dorsal measurements taken between the junction in the 
midbrain/hindbrain 
 
Table 21: Measurements of the eye for pax6.1 and midbrain-hindbrain junction for pax2.1 
 
 















Mean 13,3 5,1 5,2 
Standard 
Deviation 
2,0 0,4 0,5 
p-value >0.05 n.s   












Mean 12,8 4,1 5,9 
Standard 
Derivation 
1,0 0,4 0,3 
p-value <0,05 significant   















Mean 12,5 4,5 4,5 
Standard 
derivation 
2,3 1,2 0,4 



































Mean 9,3 3,8 4,4 
Standard 
deivation 
1,6 0,5 0,7 
p-value  < 0.05 significant   






























Mean 9,3 3,7 4,6 
Standard 
Deviation  
1,6 0,4 1,1 
p-value < 0.05 significant   














































Mean 8,93 3,5 4,5 
Standard 
derivation 
1,6 0,7 1,0 
p-value < 0.05 significant   
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10.3.2. Pictures for the measurements of the Pax2.1 and pax6.1  
 
















































































48 hpf zebrafish embryos with 1%Ethanol 
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